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CHAPTER I
INTRODUCTION
Elastin is one of the major connective tissue proteins and is present in virtually every organ of the body.

It is unique in that it is a

protein with both elasticity and tensile strength.

Elastin is found in

both "yellow" and "white .. connective tissue (tissue with a high content
of elastin is designated as yellow, while tissue with a high content of
collagen is designated as white).

It is the functional protein component

of the elastic fiber and displays an amorphous, highly refractive, generally wavy appearance under light microscopy.

Upon stretching of the elas-

tic fibers, the waviness disappears and increased birefringence is displayed.

These properties are attributed to a parallel arrangement of the
elastin polypeptide chains within the elastic fiber upon stretching 1.
Specific stains for elastin have long been in use in light microscopy.

Classic stains for elastin are Verhoeff's hematoxylin, resorcinfuchsin, and orcein 1 ' 2. Other stains used to visualize elastic fibers
include Nile blue sulfate, basic fuchsin, osmic acid, Sudan black, and
Mallory's aniline blue stain, which distinguishes between elastin and
collagen 3 ' 4. Electron microscopy stains, such as uranyl acetate and
lead citrate, allow the visualization of the surrounding microfibrillar
component, while elastin itself remains mostly unstained 1. Thus, the
ability of mature elastic tissue to take up light microscopy stains resides either in the presence of unreacted aldehydic groups within the
elastic matrix or in the strong hydrophobic nature of the protein S,fi
1

2
From microscopy and biochemical studies, it has been determined that

elastic tissue is comprised of water (approximately 70%), a microfibrillar protein component, lipids, carbohydrates, and the protein elastin 7 ' 8 .
It has been observed that elastin can be found wherever elasticity and
tensile strength are required, primarily in structures which display high
deformation under small loads and complete recovery after removal of that
load.

Therefore, elastin is in great abundance in the ligamentum nuchae

of ungulates, the vertebral ligamenta flava, aorta, lung, and pulmonary
arteries of all primates 1. Specialized forms of elastic tissue include
elastic cartilaginous tissue, such as the ear and epiglottis.

Bronchi,

skin, adipose tissue, and loose connective tissues are included as elastic tissue even though low in elastin content 1 (Table 1).
A unique property of elastin is its almost complete resistance to
methods normally used to solubilize other proteins.

This was first ob-

served by Richard and Gies who subjected elastin to boiling water which
served to gelatinize and remove collagen 9 These investigators noted
elastin's resistance to alkali degradation and its non-polar nature,
which was attributed to a high carbon to oxygen ratio.

Finally, they

demonstrated that elastin peptides aggregated upon heating.

This coacer-

vation, which represents a form of precipitation, is believed due to a
high content of non-polar amino acids in the elastin molecule.
Using x-ray diffraction studies, Lloyd and Garrod observed structural similarities between elastin and lightly vulcanized rubber in that
both lack molecular orientation 10 . It was determined that elastin is
not a true rubber since it requires water as a lubricant.

Elastin con-

sists of randomly coiled polymer chains which are joined together by

TABLE 1
ELASTIN CONTENT OF CONNECTIVE TISSUES FROM DIFFERENT ANIMALS
Species
Human
Bovine
Porcine
Dog
Rat
Chick
Rabbit
Guinea pig
Hamster

Aorta

Lung

Uterus

47.1
48.2
45.0
40.0
40.6
58.5
17.4
25.0
22.0

24.0
6.0
24.6
15.7
13.4

6.2

12.0

6.0

4.2

Ear·

Ligament
66.0

1.0 '

0.9
1.5
0.9
0.8

4.0

2.4

Elastin content is expressed as percentage of the salt-extracted, freeze-dried tissue.
Whole lung excluding major pulmonary vessels and bronchi.
From Starcher and Gallone (101)

w
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cross-links into an extensible three-dimensional network.

The cross-

links are the derived amino acids, desmosine and isodesmosine, identified
by Partridge and co-workers 11 , 12 These cross-links are responsible for
the characteristic physical properties of the elastin molecule, i.e., its
rubber-like elasticity and almost complete insolubility.
The catabolic turnover rate of elastin is low relative to other proteins.

Therefore, changes in tissue content as well as structural composition of elastin is altered principally by de~ syntheses l, 13 . Perhaps the most dramatic changes in elastic tissue and elastin have been

observed in the arteries,

and skin of various species with age.

A

in these organs with age has also been observed. This observation may be related to elastin content 1 , 9,13, 15 ,18, 21,22

11

brittleneSS

lung~,

11

Elastin has been implicated in several disease states (Table 2).
It has been suggested that changes in elastin may play a role in alterations which occur in blood vessels during degenerative arterial disease,
as it is common to see alterations in the microscopic elastic network of
these vessels during the disease state 1, 9, 13 • There is some evidence
that certain pulmonary disorders, such as emphysema, may be associated
with changes in the elastin content of the lung. 1, 9, 19 , 20 . Finally,
elastin may be involved in certain hereditary skin diseases 1 , 9 , 23
Thus it would be advantageous to know the amount and composition of
elastin in normal conditions in order to understand the various pathological processes involved in the mentioned disease states.

However, this

information is lacking in that the major source of data pertaining to the
amount of elastin is derived from gravimetric determinations on the
residue remaining following the extraction of minced or milled samples.

TABLE 2
EFFECTS OF DISEASE ON ELASTIN AND RELATED FEATURES

DISEASE

HISTOLOGIC
ABNORMALITY

FUNCTIONAL
ABNORMALITY

ATHEROSCLEROSIS

FRAGMENTED ARTERIAL ELASTIC LAMELLAE WITH CALCIUM
AND LIPID DEPOSITS AND INTIMAL THICKENING.

t

VESSEL STIFFNESS 1 VASCULAR
OCCLUSION AND TEARS,

EMPHYSEMA

FRAGMENTED ELASTIC FIBERS
PRESERVATION OF MICROFIBRILS
DESPITE DESTRUCTION OF AMORPHOUS ELASTIN,

t

COMPLIANCE OF THE LUNG AT
LOW LUNG VOLUMES,

PsEUDOXANTHOMA
ELASTICUM

FRAGMENTED ELASTIC FIBERS 1
GRANULAR DEPOSITS IN PLACE
OF AMORPHOUS ELASTIN,

t

CoMPLIANCE OF SKIN AND
FRAGILE VESSELS,

FROM SANDBERG ET, AL, (1)

U1

TABLE

2

(CoN'T)

EFFECTS OF DISEASE ON ELASTIN AND RELATED FEATURES

DISEASE

BIOCHEMICAL
ABNORMALITY

ETIOLOGIC
DEFECT

ATHEROSCLEROSIS

+ELASTINJ +COLLAGEN CONTENT AND +CALCIUM AND
LIPID CONTENT OF ELASTIN
+POLAR AMINO ACID AND CROSSLINKS IN ELASTIN,

PossiBILITIEs: RESPONSE
TO INJURY; MONOCLONAL ORIGIN
OF PLAQUES; CLONAL SENESCENCE,

EMPHYSEMA

EARLY +ELASTIN CONTENT AND
+ELASTIN SYNTHESIS, LATE:
+ELASTIN SYNTHESIS AND
POSSIBLY +ELASTIN DEGRADATION, LATER: NORMAL ELASTIN CONTENT: +POLAR AMINO
ACIDS OF ELASTIN AND POSSIBLY
tPROTEOGLYCANS,

POSSIBILITY: IMBALANCE BETWEEN ELASTASE AND INHIBITOR
SYSTEMSJ PERHAPS IN RESPONSE
TO EXOGENOUS AGENTS OR GENETIC
FACTORS,

PsEUDOXANTHOMA
E~ASTICUM

PoLYIONIC DEPOSITS ON
ELASTIC FIBERS,

SPECULATION: POLYIONIC DEPOSITS (POSSIBLY GLYCOPROTEINS) ATTRACT CALCIUM AND
CAUSE ELASTIN DAMAGE,
0'\
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The determinations are, at best, tedious and somewhat non-reproducible
and subject to various problems including sample degradation 14 , 24 - 26.
In the gravimetric procedures the extraction conditions are varied, and
so are the results.

These extractions include: 1) extraction with 1%
sodium chloride followed by several cycles of autoclaving 14 , 27 , 28 ; 2)
extraction with hot 0.1 mol/L sodium hydroxide 14 , 18 , 28 - 31 ; 3) extraction with formic acid 14 , 32 , 33 ; and 4) extraction with 5 mol/L guanidine
followed by treatment with collagenase 14 , 34
A methodology for the study of elastin currently under development
focuses on the two cross-linking amino acids, desmosine (Des) and isodesmosine (Ide).

These amino acids have only been found in the protein
elastin and in the non-elastin protein in egg shell membranes 35 - 38 .
Thus, their quantitation may be used as an index of the elastin content
of tissue, just as hydroxyproline is used as an index of the amount of
collagen present in a tissue 39 , 49 .
Although various chromatographic methods have been developed for the
purification and quantitation of Des and Ide 37 , 41 - 48 , few studies employ
amino acid quantitation as an index of elastin content 39 , the chromatographic procedures being tedious, cumbersome, and limited in their scope
of application.

The few studies utilizing the desmosines for the estima-

tion of elastin employed automated amino acid analysis, a technique which
is both costly and time consuming.
FUNCTIONAL ASPECTS OF ELASTIN
Many of the physical properties of the elastin molecule resemble
those of the rubber molecule 50 However, elastin is not believed to be

8

a largely random network of cross-linked

chains~

like rubber.

In contrast

it is believed to be a network of cross-linked chains containing significant ordered structure 51 Several models have been proposed to explain
its functional aspects, as well as its high degree of organization 50 - 56 .
Partridge envisioned elastin as tetrahedrally packed, globular protein subunits, with the hydrophobic residues turned inward with the crosslinks protruding from the surface 50 . Using this model, Weis-Fogh and coworkers suggested the functional properties occur by polar-apolar interactions, as the hydrophobic core of the globular subunits are exposed to
an aqueous environment upon stretching 52 •
Another

the random chain, is supported by evidence suggesting
that the elastin chains are in rapid Brownian motion 53 , 54 . This model
is also supported by classical thermodynamic considerations 53 , 54
model~

A third model, the ••oiled-coil"~ has been suggested by Gray and coworkers 55 They claim that the regions of the elastin molecule which
contain the cross-links are separated by regions composed predominantly
of

glycine~

proline, and valine.

left handed coil

11

They view these regions as a broad
11

with the hydrophobic residues on the inside and the hy-

drophilic residues on the outside.

Upon extension of the molecule, the

coil would be opened, which would expose the hydrophobic groups to a more
polar environment.

This configuration would be thermodynamically un-

favorable and the molecule would tend to return to its original state.
A fourth coiled model is suggested from the observation that the
repeating sequences in the elastin molecule predominantely represent a
single secondary structural feature, the S-turn 56

9

COMPONENTS OF ELASTIN BIOSYNTHESIS
The biosynthesis of elastin is a complex process that includes: synthesis of a microfibrillar component by fibroblasts; synthesis of an
elastin precursor, tropoelastin; and finally, the formation of the mature
elastin fiber by the action of lysyl oxidase.
Microfibril Component:
The non-elastin component of the elastic fiber is the microfibril 13 .
This glycoprotein component is referred to as a structural protein, but
its exact function has not been determined 1. These fibers, which are 10
to 20 nm in diameter, are synthesized by either the fibroblasts or the
smooth muscle cells 49 , 57 , 58 . This protein lies adjacent to either the
fibroblast or the smooth muscle cell (which also produce elastin) responsible for its synthesis.

The microfibrils are laid in bundles parallel to

the long axis of the developing elastin fiber.

These fibers may represent

the first immature elastin fibers, and as the elastin matures, the microfibrils are found in the interstices and around the periphery of the elastin fiber.

There has been some evidence that, in certain areas, these
microfibrils display periodicity and take on a beaded appearance 1
The amino acid content of the microfibrils is dissimilar to that of elastin as evidenced by the presence of histidine, methionine, and cystine,
and the lack of Des and Ide.

Also, the non-polar to polar amino acid
ratio differs from that of elastin 13 . The microfibrils have been shown

to contain at least two glycoprotein constituents, designated MFP 1 and
MFP 2 59 . MFP 1 is a collagenous glycoprotein of 150,00 daltons while

10

MFP 2 is a non-collagenous glycoprotein of 300,000 daltons 59
Tropoelastin:

Concomitant with the synthesis of the microfibrils is the synthes~s
of tropoelastin, or soluble elastin 58 Tropoelastin is synthesized from
the same fibroblasts or smooth muscle cells as the microfibrils, and was
first isolated by Smith and co-workers from the aortas of copper-deficient
swine 60 Since this discovery other native soluble elastin molecules
have been isolated from the aorta of various species including copper-deficient chicks 61 , lathyritic chicks 62 , 63 , and from the ligamentum nuchae of copper-deficient calves 64 .
Tropoelastin is composed of a single polypeptide chain of approximatly 800 residues (68,000-72,000 daltons) 65 , 66 . At present only 70%
of the sequence is known, but it is clear that the majority of the residues are non-polar amino acids, such as glycine, proline, alanine, valine,
phenylalanine, isoleucine, and leucine.

The small number of polar amino

acid residues, such as aspartic acid, glutamic acid, arginine, and lysine
lend solubility to the molecule.
The amino acid content of a tropoelastin preparation is given in
Table 3.

Tropoelastin usually contains little or no histidine.

lacks methionine, and other sulfur-containing amino acids.

It also

Arginine is

present in minimal amounts while the remainder of the molecule consists
largely of apolar amino acids.

For these reasons, the purity of tropo-

elastin is sometimes measured by the absence of histidine and methionine
in protein hydrolysates 67 . Hydroxyproline, a major component of collagen (40%), is found in relatively small amounts (5%) in the tropoelastin

11

TABLE 3
AMINO ACID COMPOSITION OF SOLUBLE AND MATURE
<INSOLUBLE) ELASTIN FROM THE PIG

AMINO AciD
GLYCINE
ALANINE
PROLINE
HYDROXYPROLINE
VALINE

SOLUBLE
ELASTIN

MATURE
ELASTIN

245
187
91
7
103

256
181
90

3

92
14
41
12
25
5
5
25
5

10

11

8

11

12

16

0-1

1

ISOLEUCINE

14

LEUCINE

ARGININE

41
14
24
4

LYSINE

37

TYROSINE
PHENYLALANINE

CROSS-LINKS*

8

VERY LOW

ASPARTIC ACID AND
ASPARAGINE
THREONINE
SERINE
GLUTAMIC ACID AND
GLUTAMINE
METHIONINEJ CYSTEINEJ
TRYPTOPHAN AND
HISTIDINE
HUMAN ELASTIN HAS A SIMILAR COMPOSITION,
BASED ON AN ASSUMED CHAIN LENGTH OF
* - EXPRESSED AS LYSINE EQUIVALENTS,
ALSO INCLUDED IN THIS ESTIMATE,

800

RESIDUES,

A NUMBER

ACTUAL LYSINE EQUIVALENTS IN

DESMOSINE AND ISODESMOSINE ARE EIGHT TO
FROM SANDBERGJ ET, AL, (1)

OF INTERMEDIATES ARE

10,

12
molecule.

Other hydroxylated amino acids are not found in the tropoelastin molecule 68 .

All methods for the purification of the tropoelastin molecule are
usually performed in the presence of proteolytic inhibitors 61 - 63 , 67 , 69 .
This is necessary due to the susceptibility of the tropoelastin molecule
to cleavage by various proteases which are often associated with the soluble elastin fractions 13 , 70
Recently, there has been some discussion of the existence of a precursor of tropoelastin 71 , 72 . Rucker and co-workers have postulated that
tropoelastin is derived from a soluble protein of approximately 95,000
daltons 71 . These investigators used aortas from copper-deficient chicks
and a 1-antitrypsin at each step of purification. With this modification
they were able to detect a pre-tropoelastin. Their conclusions were
based on terminal amino group analysis of the molecule which they state
is the same as tropoelastin.

Also, the amino acid composition of the

pretropoelastin is similar to that of tropoelastin.

It contains a limit-

ed number of aldehydic functions and is a viable candidate for action by
lysyl oxidase.

The pre-tropoelastin was found in greater concentrations

in the aortas from the copper-deficient chicks.
Foster and co-workers have reported the isolation of a proelastin,
120,000-130,000 daltons, from lathyritic chick aorta and second passage
aortic smooth muscle cells from rabbits 72 . Using a pulse-chase technique, involving the incorporation of 3H-valine and 14 c-proline, they observed a high molecular weight soluble protein.

When chased for a period

of 30 minutes to 1 hour, its concentration decreased with the concomitant
appearance of the 70,000 dalton tropoelastin.

Direct identification of

13

the high molecular weight protein as a precursor to tropoelastin was provided by amino acid analysis.

The amino acid composition of the high

molecular weight peak was very similar to that of tropoelastin.

Foster

also reported finding a soluble protein of 90,000-100,000 daltons which
had also been identified by Rucker 71 . This was added evidence of the
existence of a pro-elastin molecule.
These findings are controversial.

Rosenbloom and co-workers found

that the presumed pro-elastin contained considerable amounts of histidine
while tropoelastin and elastin contained little, if any 73 . Rosenbloom
used a hisitidine analog, histidinal, that would inhibit elastin biosynthesis if pro-elastin were a precursor to elastin.

They found that while

collagen synthesis was markedly inhibited by histidinal, tropoelastin
synthesis was relatively unaffected.

By using pulse-chase experiments

they observed that the labeled tropoelastin was efficiently incorporated into insoluble elastin both in the presence and absence of histidinal.

From these findings, Rosenbloom suggests that tropoelastin was

the primary precursor in elastin biosynthesis in chick aorta.
Lysyl Oxidase:
Lysyl oxidase is the major enzyme responsible for the conversion of
tropoelastin to mature elastin.

This enzyme has been shown to catalyze

the reaction of the peptidyl lysine residues in the tropoelastin molecule
to lysinal.

This reaction is necessary if the cross-links found in the

mature elastin molecule are to occur.

Lysyl oxidase has been detected in

numerous connective tissues and smooth muscle cells in vitro.

It has

been shown to be involved in the oxidation of peptidyl lysine to lysinal
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in both elastin and collagen biosynthesis 74 . The enzyme has been found
in close association with its substrate, tropoelastin, and has an absolute requirement of copper for maximal activity 7S- 78 .
There is also evidence that the enzyme exists in various forms 98 .
Two isozymes of S9,000 and 61,000 daltons, A and B respectively, have
been isolated from bovine aorta 78 . It is unclear which form predominates

Another lysyl oxidase of approximately 180,000 daltons
has been isolated from bone although its function is not yet known 79
~vivo.

BIOSYNTHESIS OF ELASTIN
Three components of elastin biosynthesis (microfibrils, tropoelastin, and lysyl oxidase) work in concert to form the mature elastin fiber.
The general scheme is as follows: first, the fibroblasts or smooth muscle
cells synthesize the microfibrils which are then deposited along the
small infoldings on the surface of the cell

sa.

Second, perhaps concomi-

tant with the synthesis of the microfibrils, tropoelastin is synthesized
intracelluarly on the ribsomes

sa.

Once tropoelastin is synthesized, it

is transported outside the cell by an unknown mechanism

sa.

Here the en-

zyme lysyl oxidase oxidizes the E-amino groups of the lysine residues to
aldehydes.

These aldehydes condense, via Schiff base reaction, to form

the cross-links in the elastin molecule

sa.

As the modified lysine resi-

dues condense, tropoelastin loses its solubility and aggregates around
the microfibrils, possibly by electrostatic interaction between the two
molecules, forming the mature elastin molecule 58
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Mature Elastin:
In its mature form, insoluble elastin is composed of 4 soluble elastin subunits (tropoelastin) that are intermolecularly cross-linked into
a fibrous network.

Elastin, as in tropoelastin, maintains a predomin-

ance of non-polar amino acids, with less than 5% polar amino acids
(Table 3).

This predominance of non-polar amino acid residues seems

unique to elastin and is, therefore, a good means of identification.
One of the main differences between tropoelastin and elastin is the
greater lysine content of the former (Table 3).

While the tropoelastin

molecule contains up to 40 lysine residues per 1000, the elastin molecule
may contain only 3 to 8.

This decrease in the amount of lysine is due

to a direct conversion of lysine into cross-links.

As a consequence of

these cross-links, a highly polymerized and insoluble protein is produced 13 .
Elastin is similar to collagen in that it contains large amounts of
the amino acids glycine, valine, alanine, and proline.

In fact, due to

the large amount of valine and proline incorporated in the elastin molecule, these amino acids, when labeled with a radioisotope, are used as
an index of elastin biosynthesis 79 . Elastin contains approximately 10%
as much hydroxyproline as collagen and contains no hydroxylysine.

Elas-

tin and egg shell membrane protein are unique in that they are the only
proteins so far analyzed found to contain Des and Ide , which account for
approximately 1% by weight (Fig. 1).
The amino acid composition of elastin has been shown to vary slightly between tissues from the same species.

A slight variation has also

been observed in the same tissue from various species.

In both cases,
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Structure of desmosine and isodesmosine.

the variability lies mainly in the non-polar amino acids (Table 4).
variability may be due to the purification methods utilized 80 , 81 .
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Much of the elastin molecule appears to be comprised of repeating
sequences in the form of tetra-, penta-, and hexa-peptide units 13 • For
example, common tetra-, and penta-peptide sequences are Gly-Gly-Val-Pro
and Pro-Gly-Val-Gly-Val, respectively.

The repeating hexa-peptide unit

common to elastin is Pro-Gly-Val-Gly-Val-Ala-.

There also seems to exist

a homology with respect to the N-terminal portion of the elastin molecule
from unrelated species 61 , 62 .
Another structural feature which seems common to the repeating sequences in the peptide chain is the beta turn 82 . With this beta turn
present, the elastin chain is able to fold back on itself.

These beta

turns, when repeated several times, impart a unique structure to the
elastin molecule, known as the beta spiral.

This beta spiral is not

known to occur in any other mammalian protein and may be important in the
formation and function of the elastin fiber 1' 82 •
One other feature which seems to set elastin apart from other proteins is its alanine enrichment 1 In the tropoelastin molecule, lysine
residues almost always occur in pairs, and it is in these regions where
alanine enrichment seems to occur.

That is, the lysine pairs are separa-

ted by anywhere from 1 to 3 alanine residues and can be preceded by as
many as 8 alanine residues in the sequence 83 , 84 . It appears that the
alanine enrichment is essential for the cross-linking of the lysine residues in the molecule 1 .
From studies on these restricted areas of alanine enrichment, it has
been proposed that a specialized structure exists in the cross-link areas,

TABLE 4
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possibly an a-helical structure . Thus it appears that the elastin has
a dual nature: one of an extensible portion which contains the hydrophobic amino acids; and another compact region, rich in alanine, which contains the lysine residues responsible for the formation of the crosslinks in the mature elastin molecule 1.
Cross-Linking Amino Acids in Elastin:
All the known cross-links found in elastin are derived from peptidyl
lysine 3 . These cross-links account for elastin's low modulus of elasticity and its inherent rapid and reversible extensibility.

These cross-

links maintain the gross structure of the protein as well as limit the
amount of extensibility under stress.
LaBella and co-workers found initial evidence for a cross-linking
substance in 1963 when they reported finding a fluorescent component with
a yellowish pigment in a partial hydrolysate of thoracic aorta elastin 86 .
These investigators found that a single substance was responsible for the
fluorescence at 405, 440, and 460 nm and that the fluorescence increased
with age.
Partridge and his group were studying elastin by degradation with
proteolytic enzymes 86 , 87 . In partial hydrolysates they found amino
acids, small peptides, and an additional fraction.

This fraction con-

tained a component which had a molecular weight higher than ordinary
amino acids, yet was not a polypeptide 86 , 87 . When this fraction was
collected it was bright yellow in color and gave the characteristic bluewhite fluorescence of elastic tissue.

The fraction was then subjected

to further hydrolysis and two peaks were resolved by ion-exchange chroma-
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tography 86 , 87 . These two peaks were found to be very hygroscopic and
upon titration each peak displayed 4 pK•s 12 . When the absorbance specof the two compounds was determined, compound A displayed two absor11

11

bance maxima, 235 and 268 nm, while compound 8 displayed only one maxi11

mum at 278 nm.

11

The spectra of compounds A and B were compared to spectra

of model compounds.

It was determined that the structures resembled the

trimethylpyridines 11 . The structures of these compounds were elucidated through these studies, as well as infrared and nuclear magnetic resonance spectroscopy (Fig. 1).

Compound A was termed desmosine while

compound B was termed isodesmosine.

Both compounds had a MW of 543.

Biosynthesis of Desmosine and Isodesmosine:
Partridge and co-workers were among the first to determine that the
cross-links in elastin were derived from peptidyl lysine 11 , 12, 35 - 37, 83.
They observed that when the desmosines were oxidized with alkaline ferricyanide, the pyridinium ring was destroyed and lysine was liberated.
Using pulse-chase techniques, other workers found that when 14 c-lysine
was incubated with aorta from chick embryos for 24 hours, the label appeared in elastin, while the desmosines remained unlabelled 89 , 90 . Following a 7 day chase period of cold lysine, they observed that the desmosines became heavily labelled 89 .
Partridge then injected rats with 14 c-lysine daily for a period of
10 days and isolated the desmosines and lysine from hydrolyzed aortic
elastin 9
From these studies they determined that the ratio of radio-

°

activity of desmosine and isodesmosine to lysine was 4 and that it required approximately 17 days for this ratio to occur.

Ultimately Part-

21
ridge suggested a biosynthetic pathway whereby 4 neighboring lysine molecules have 3 of their E-amino groups deaminated oxidatively, and then
cyclize to form a pyridinium ring 58 , 90 .
Diets deficient in copper and/or containing lathyrogenic agents,
such as s-aminopropionitrile (BAPN) or semicarbazide, inhibit the synthesis of elastin.

These same agents were found to inhibit the biosynthe-

sis of the desmosines.

The inhibition displayed in by a copper deficient

diet is based on the fact that lysyl oxidase requires copper for activity.

The inhibition by BAPN or semicarbazide is due to their binding

of the aldehyde functions after the catalytic action of lysyl oxidase.
Using two techniques for inhibiting desmosine and isodesmosine synthesis, O'Dell and others found other minor cross-links were possible in
elastin biosynthesis 91 . They utilized aorta organ culture techniques
in the presence of lathyrogenic agents with a copper-deficient medium.
They observed that the rate of 14 c-lysine incorporation into elastin was
not affected, but the rate of labeled lysine incorporation into desmosine and isodesmosine was greatly reduced.

From these results they determined that other cross-links in elastin were possible 91 , 92 .

Miller and co-workers found the condensation product of two lysine
molecules in which one of theE-amino groups is deaminated 93 . This condensation results in the formation of lysinonorleucine (Fig. 2).
Partridge found that elastin which had been reduced with -sodium
borohydride and hydrolyzed by acid gave a peak which overlapped with lysinonorleucine on amino acid analysis 88 . This compound was found to
have an 18 carbon backbone with a molecular weight of 436 and was termed
merodesmosine.

It could be derived from the condensation product of 3
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lysine residues (Fig. 2).

With further studies, it was determined that

merodesmosine could result from two reactions: 1) the condensation of the
Schiff base of lysinonorleucine (dehydrolysinonorleucine) with a lysine
residue; or 2) the condensation of 2 aldehydic functions from lysine residues with another lysine residue.

Both pathways resulted in the forma-

tion of dehydromerodesmosine which can then be reduced to merodesmosine.
In summary, the biosynthetic pathway suggested by Partridge seems
the most plausible 94 - 97 . The key step in the pathway seems to be the
oxidative deamination of the s-amino groups of selected lysine residues,
yielding a-aminoadipic acid-o-semialdehyde.
ed by the action of lysyl oxidase.

This reaction is accomplish-

The aldehyde can then react in one of

two ways: 1) formation of a Schiff base with a lysine residue yielding
dehydrolysinonorleucine; or 2) condensation with another aldehyde via an
aldol condensation.

Dehydrolysinonorleucine can be further reduced to

form lysinonorleucine or can form 4-hydroxy-2,3-dehyroisodesmopipyridine
via combination with an aldol condensation product.

This compound can

then be dehydrated to form 2,3,4,5-dehydroisodesmopipyridine, which can
spontaneously undergo oxidation to form isodesmosine (Fig. 3).

If the

aldol condensation product unites with a lysine residue to form dehydromerodesmosine, merodesmosine can be synthesized by a simple reduction.
However, if the dehydromerodesmosine reacts with a-aminoadipic acid-asemialdehyde, 2-hydroxy-5,6-dehydrodesmopipyridine is formed, which can
spontaneously dehydrate to form 2,3,5,6-dehydrodesmopipyridine.

Desmo-

sine can then be synthesized by an oxidative reaction (Fig. 3).
Studies with model aldehydes and amines suggest that after the
initial enzymatic oxidation of the s-amino groups to lysyl residues, the
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above reactions occur spontaneously 98 , 99 .
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The amino acid sequences around the cross-linking regions have been
elucidated 11 , 100 . These areas are rich in alanine and also contain a
high percentage of serine, glutamic acid, phenylalanine, and tyrosine.
It was proposed by Foster and co-workers that lysines, which are preceded and followed by alanine or glycine, are oxidized, but those lysine
residues followed by large hydrophobic amino acids (particularly tyrosyl
residues) do n~t undergo oxidation 100 • Thus, the placement of the tyrosyl residues may determine the positions where cross-links are not
formed 69,100

CHAPTER 2
PROPOSAL
The aim of this research project is to devise a more rapid and accurate method for the quantitation of the desmosines and there
timation of the elastin.

~re

the es-

One possible method of quantitation, proven to

be both rapid and accurate for minute amounts af analytes, is the immunoassay.

In all immunoassays, there is one basic reaction:
Ab + Ag--+ Ab Ag

where Ab is the antibody produced against a specific antigen Ag.

This

reaction depends on the specificity of the Ab for the Ag in forming the
Ab•Ag complex.

In this simple reaction, either the depletion of the Ab

or Ag or the appearance of the Ab•Ag complex may be quantitated.

How-

ever, this quantitation is usually difficult due to the amounts of Ab or
Ag present in the reaction, and the minute amount of Ab·Ag complex formed.
To aid in the quantitation, a label is introduced into the assay system.
The classical label for such immunoassays is a radioisotope which
can be attached to the Ag.

In this case the reaction for a radioimmuno-

assay (RIA) is as follows:
Ab + Ag +

Ag*~Ab·Ag*

where Ag* is the labeled antigen.

+ Ab·Ag + Ag + Ag*

Due to the effect of mass action, the

amount of Ag* bound to the Ab is proportional to the concentration of the
unlabeled Ag.

Thus, by varying the amount of Ag, and maintaining the Ab

and Ag* at constant concentrations, a standard curve for the Ag may be
constructed.

The remaining necessity in RIA involves the separation of
26
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the Ab•Ag* complex from the Ag*.

Because this step involves a physical

separation (double antibody; activated charcoal; solid phase separation),
RIA is considered a heterogenous immunoassay technique.
While RIA is a sensitive and accurate assay it has its drawbacks.
One, for example, is the fact that the assay employs a radioisotope which
must be handled and disposed of properly.

Secondly, RIA's tend to have

a short storage life and are expensive.
Due to these drawbacks, a different type of immunoassay has been
developed.

This assay relies on the basic immunoassay reaction, but the

label is an enzyme rather than a radioisotope.

Instead of determining

the activity of the isotope, enzyme activity is a measure of the Ag in
the assay.

This technique, developed by Syva, Palo Alto, Ca., is called

an enzyme multiplied immunoassay technique (EMIT~, and relies on an
artificially produced phenonmenon by which the enzyme activity can be
controlled by any desired substance 103 .
In this system, the enzyme is activated by minute quantities of Aq,
and this activity is proportional to the concentration of the Aq present.
This type of assay is developed by first conjugating the Aq or hapten
(compound of less than 1000 daltons, which by itself does not elicit an
antigenic response from the host) to an enzyme 103 . The conjugation is
regulated such that the conjugation site is in the proximity of the reactive site of the enzyme 103 . Finally, specific Abare produced
against the Ag or hapten (Hp).
With the addition of the enzyme substrate to the reaction mixture
which contains the Ab and the enzyme-Ag (Hp) conjugate, no activity is
detected.

This inhibition is thought to be due to the inability of the
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substrate to reach the active site of the enzyme due to physical blocking
of the site by the Ab 103 . If, however, free Ag (Hp) is added to thereaction mixture, there will be competitive binding between the Ab and the
enzyme-Ag (Hp) conjugate or the free Ag (Hp), allowing the enzyme toreact with

it~

substrate, thereby displaying activity proportional to the

amount of free Ag (Hp) present.

As the concentration of the free Ag

(Hp) increases, the Ab binds more of the free Ag (Hp) allowing more of
the enzyme to react with its substrate, further increasing its activity.
By varying the concentration of the free Ag (Hp), a standard curve may
be constructed of the concentration of the free Ag (Hp} vs. enzyme activity.

This type of assay is termed a homogenous immunoassay because no

physical separation step is required.
Several enzymes are employed with this type of assay, including egg
white lysozyme (EC 3.2.1.17), and glucose-6-phosphate dehydrogenase (G6-PDase EC 1.1.1.49).
Thus, the first part of this research project is to apply this type
of assay to quantitating desmosine, and isodesmosine.

First, they are

conjugated to a carrier protein such as bovine serum albumin (BSA).
Once conjugated, antibodies to both desmosine and isodesmosine can be
produced using rabbits.

Concomitant with the conjugation of the desmo-

sines to BSA, desmosine and isodesmosine are conjugated to several enzymes, including lysozyme and glucose-6-phosphate dehydrogenase.

Once

these preliminary steps are achieved, an enzyme immunoassay system is
possible for the quantitation of the desmosines.
Another potential method for the quantitation of the desmosines from
elastin is amino acid analysis via high performance liquid chromatography
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(HPLC).

Several methods now exist for amino acid analysis by HPLC utilizing several different separation techniques 104 - 106 . These techniques
include the derivatization of the amino acids with a fluorogenic compound
followed by reverse phase HPLC separation 104 , separation of underivatized amino acids by ion-suppression 105 , or the separation of the amino
acids by ion-exchange HPLC 106 . Another possible means of separating the
amino acids is by ion-paired HPLC, which in essence creates a pseudo-ionexchange column and also employs some of the characteristics of a reverse
phase column.
High performance liquid chromatography is a technique whereby a complex mixture can be readily separated and each component quantitated.
While its fundamental theories were drawn from gas liquid chromatography
(GC), HPLC has supplanted GC in many areas of analytical work, especially
in the analysis of non-volatile or thermally labile compounds.
An HPLC system usually consists of a pump, a column, and a detector.
Of these three, the column is the most important for it is the column
which actually does the separating of the various components of the mixture.

It achieves this separation by the interaction of the compound

with both the stationary phase (column packing) and the mobile phase
(eluting solvent).

This interaction varies according to the stationary

phase and the mobile phase employed in the separation.
The interaction of the compound with the various phases on the
column can be quantitated by the various parameters, k', a, Rs, and N.
The capacity factor, k', is a measure of the retention of the compound
on the column for that particular system.
equation:

It can be calculated by the
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v1 - vo
k'

=
vo

where v is the retention volume of the compound of interest; v0 is the
1
void volume of the column.
The separation factor, a, is a measure of the ability of the chromatographic system to separate two components of a mixture, and is defined
as the ratio of the k' of the two components:
a=

k'

_2_

k'1
where k2 is the capacity factor for the longer retained component.
The resolution factor, Rs, expresses the separation of the two peaks
and includes the average peak width as well as the peak to peak separation.

It is calculated as follows:
R =

v2 - v1

-____;;;~__;;;..,__

s

1/2(w + w2)
1
where w and w2 are the width of the two peaks at the baseline. Baseline
1
resolution of the two peaks would correspond to an R5 value of 1.5 119 .
Finally, the theoretical plate number, N, which is a term used for
comparative purposes, describes the efficiency of the column.

The ef-

ficiency is calculated as follows:
N

= (t/w) 2

where t r is the retention time of the peak and w is the width (em) of
the peak at baseline. With this number the efficiency of two different
columns can be compared for a particular compound providing all other
operating parameters remain constant.
As stated earlier, there are different types of HPLC.

These include
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adsorption or liquid-solid chromatography, partition or liquid-liquid
chromatography, and ion-exchange chromatography.

In adsorption chromato-

graphy, the components to be separated are bound to the surface of the
column packing, and this bonding is dependent on the functional qroups
on the molecule.

The common adsorbants are silica gel and alumina.

In

adsorption chromatography the stationary phase is polar while the mobile
phase is non-polar.
In ion-exchange HPLC, retention is the result of two simultaneous
processes: 1) the distribution of compounds between the mobile phase,
usually polar, and the organic stationary phase; 2) reaction with the
ionic sites within the stationary phase.

These ionic sites usually con-

sist of R-so 3- groups for cation exchange columns or R-N(CH 3); groups
for anion exchange columns. Classically, ion-exchange columns have been
utilized for amino acid analysis.
Partition chromatography relies on the partitioning of the solute
between two phases, mobile and stationary, and the functionality of the
solute for separation.

This type of chromatography is the most widely

used method for HPLC analysis.

Partition chromatography is divided into

two types, normal and reverse phase.

In normal phase, so named due to

historically being the first used, the stationary support is coated
(bonded) with a polar moiety, while the mobile phase is relatively nonpolar.

Typically, normal phase supports are bonded to cyano (CN), amine

(NH 2), or hydroxyl (OH) compounds.
In reverse phase chromatography, the stationary phase support is
bonded, via siloxanes, to non-polar groups, usually c2 to c18 alkanes.
Of these, the most widely utilized is the octadecylsilane (ODS). The
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retention mechanism for reverse phase HPLC is more complex than classical
forms.

In reverse-phase HPLC, the mobile phase is of higher polarity

than the stationary phase; thus polar substances tend to elute prior to
less polar.

This is just opposite to the results obtained from a normal

phase column.
There are 3 possibilities for the separation mechanism in reverse
phase: 1) partitioning of the solute between the non-polar stationary
phase and the polar mobile phase; 2) adsorption of the solute to the nonpolar functions of the stationary phase; and 3) partitioning of the solute molecules between the mobile phase and a new" stationary phase
11

which is the organic modifier (usually methanol or acetonitrile) added to
the mobile phase and adsorbed onto the stationary phase 107 .
Ionized compounds, such as amino acids, elute very quickly or yield
poorly defined peaks with severe tailing on a reverse phase column.
There are several ways to suppress the ionization of the molecules to aid
in their separation.

One such way is to chemically modify the ionic species by bonding another molecule of less polarity to it 104 . Usually
this derivatization process not only decreases the ionization of the rnalecule (polarity), but also usually produces a chromophore which enhances
the detection of the molecule 104 Another method for controlling the
ionization of the molecule is by controlling the pH of the mobile phase
in order to suppress the ionization of the molecule.

This technique is

called ion-suppression, and is useful for weak acids and bases in the pH
range of 2 to 8.

This technique cannot be used with strong acids and

bases which remain ionized in that pH range.
When using strong acids or bases, another technique is available for
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their separation.

With this technique the tailing and poor peak shapes

can be circumvented by forming ion pairs with a counter ion dissolved
in the mobile phase.

This ion-pair chromatography (IPC) technique has

several possible modes of retention.of a solute.

One mode is the actual

pairing between the sample and the counter ion, thereby decreasing the
polarity as shown below:
+
A(aq) + B(aq)---7AB(org)
where A+ is the aqueous sample; 8- is the counter ion in the mobile
phase; and AB is the ion paired species.

Another possible mechanism is

the conversion of the reverse phase column to a pseudo-ion-exchange column, thereby possessing both characteristics of a reverse phase column
and an ion-exchange column.

The actual separation mechanism may be a
combination of the two processes 107 .
In this part of the research, the desmosines are separated and
quantitated by several of the described HPLC techniques, including ionexchange HPLC, ion-suppression HPLC, derivatization with a fluorogenic
compound, and finally by ion paired HPLC.

CHAPTER 3
METHODS AND MATERIALS
PURIFICATION OF DESMOSINE AND ISODESMOSINE
Commercially prepared desmosine and isodesmosine (Elastin Products,
St. Louis, Mo.) were dissolved in 5.0 mL of 0.2 mol/L sodium citrate
buffer, pH 2.20.

This solution was then applied to a jacketed column,

85 x 5 em, packed with Aminex

~1s

"C" resin.

The column temperature was

maintained at 45 °C with a circulating water bath.
maintained at 12.0 mL/min.

The flow rate was

The column was first eluted with approxi-

mately 100 mL of 0.2 mol/L sodium citrate buffer, pH 3.25, followed by
1.0 L of 0.38 mol/L sodium citrate buffer, pH 4.00.

The desmosine or

isodesmosine was then eluted with 0.38 mol/L sodium citrate buffer, pH
5.65.

The eluted desmosine or isodesmosine was then lyophilized and redissolved in a minimum of 0.1 mol/L hydrochloric acid and quantitatively
transferred to a 45 x 2 em column packed with Dowex 50WX8 cation exchange
resin, 50-100 mesh, in the hydrogen form.

The salts were eluted with 3.0

L of glass distilled, deionized water at a flow rate of 9.0 mL/min and
the desmosine or isodesmosine was then eluted with 0.5 mol/L ammonium hydroxide.

This solution was then lyophilized.

Following the elution of the desmosine or isodesmosine, the hydrogen
form of the cation exchange resin was regenerated.
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AMINO ACID ANALYSIS
The purity of the desmosines, as well as the amino acid analysis of
the protein and tissue hydrolysates, was accomplished with a Beckman 121
camino acid analyzer.

The analyzer utilized an 11.0 x 0.9 em jacketed

column packed with PA-35, a sperical 7.5% cross-linked sulfonic acid resin, with a mean particle size of 13.0 ± 0.6 mm.

The column temperature

was maintained at 56 °C.
The automatic program (Fig. 4) employed for the separation and quantitation of the amino acids was as follows.

The samples were diluted

with 0.2 mol/L sodium citrate buffer, pH 2.20.

Of this dilution 0.5 ml

was injected and the column was first eluted with 0.2 mol/L sodium citrate buffer, pH 3.45 for 15 min, followed by a second elution with 0.35
mol/L sodium citrate buffer, pH 4.25 for 60 min.

The final eluting buf-

fer was 0.35 mol/L sodium citrate, pH 5.25, for a period of 60 min.

All

buffers were pumped at approximately 100 psig, at a flow of 68 ml/min.
Following the elution of the amino

acids~

the column was regenerated

with 0.2 mol/L sodium hydroxide, followed by column equilibration with
the initial buffer.

All buffers contained 0.4 ml of 25% thiodiglycol/L

to establish a reducing environment and 1.0 ml of toluene/L to retard
bacterial growth.
The eluted amino acids were detected by reaction with ninhydrin.
The ninhydrin was prepared according to the Beckman amino acid manual.
SPECTRA DETERMINATION OF DESMOSINE AND ISODESMOSINE
The purified desmosine or isodesmosine (5.43 mg each) was dissolved
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in 10.0 ml of deionized, glass distilled water, hereafter referred to as
water.

Each solution was scanned against a water blank from 340 to 190

nm with a Perkin-Elmer recording spectrophotometer.
CONJUGATION AND ANTIBODY PRODUCTION
Purification of the Glutaraldehyde Solution:
To 100 ml of commercially prepared 25% glutaraldehyde (Sigma Chemical Co., St. Louis, Mo.), 15 to 25 g of activated charcoal was added and
throughly mixed.
pore filter.

This mixture was then filtered through a 0.45

~m

milli-

This procedure of Anderson was performed several times un-

til the filtrate changed from a straw yellow color to a clear solution
with a fruity fragrence 109 . The spectrum of the purified glutaralde11

11

hyde was then recorded from 340 to 200 nm with a Beckman DB-1 recording
spectrophotometer and compared to the literature spectrum 109 .
Conjugation of the Desmosines to Bovine Serum Albumin:
The purified desmosine or isodesmosine was conjugated to bovine
serum albumin via a modified method of several authors 110 - 114 . In this
procedure, 50 mg (0.735 nmol) of bovine serum albumin (BSA) was dissolved
in 9.78 ml of 0.1 mol/L sodium acetate buffer, pH 5.0.

To this was added

24.0 mg (44.2 nmol) of desmosine or isodesmosine.

These amounts were
added to establish a desmosine or isodesmosine to BSA ratio of 60 114 .
While slowly stirring, a purified 2% glutaraldehyde solution was added
dropwise in various amounts to establish a glutaraldehyde to desmosine or
isodesmosine mol ratio of 1 to 4 114 . The mixture was allowed to react
for 3 hours at room temperature, after which the mixture was centrifuged
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at 1,000 x

~for

20 min to remove any protein-protein macro-conjugates.

The remaining supernatant was either dialyzed against water at 4 °C for
24 hours or placed on a Sephadex G-50 column (45 x 1 em) and eluted with
0.1 mol/L sodium acetate buffer, pH 5.0.
nm.

The eluant was monitored at 280

The protein conjugate eluted from the column was then dialyzed

against water for 24 hours at 4 °C to remove the buffer.

The dialysate

was then lyophilized and stored dessicated at 0 °C until needed.
All other conjugation procedures were modifications of this method.
Conjugation of the Desmosines to Lysozyme:
Purified desmosine or isodesmosine was conjugated to lysozyme (EC
3.2.1.17, Sigma Chemical Co., St. Louis, Mo.), by the method previously
described for BSA with the following modifications. Fifty mg of lysozyme
(3.47 x 10- 6 mol) was dissolved in 9.78 mL of 0.066 mol/L potassium phosphate (monobasic) buffer, pH 6.24.

To this solution was added 113 mg of
desmosine or isodesmosine (2.083 x 10- 4 mol), followed by the addition
of 1.05 mL of a 2% glutaraldehyde solution (2.083 x 10-4 mol), dropwise.
Following the conjugation reaction and centrifugation, the supernatant was dialyzed against water for 24 hours at 4 °C, lyophilized and
stored desiccated at 0 °c.
Conjugation of the Desmosines to Glucose-6-Phosphate Dehydrogenase:
Purified desmosine or isodesmosine was conjugated to glucose-6-phosphate dehydrogenase (EC 1.1.1.49, Sigma Chemical Co., St. Louis, Mo.),
grade IV, by the method previously described for BSA with the following
modifications.

One ml of a glucose-6-phosphate dehydrogenase solution,

containing 2.05 mg (2.05 x 10- 5 mol) protein, was added to 3.97 mL of a
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0.1 mol/L Tris buffer, pH 7.6.

To this was added 0.67 mL of a desmosine
or isodesmosine solution (1 mg/mL; 1.23 x 10- 4 mol). While slowly stirring, 0.013 mL of a 2% glutaraldehyde solution was added dropwise.
Following the conjugation reaction and centrifugation, the supernatant was dialyzed against water for 24 hours at 4 °C, lyophilized, and
stored desiccated at 0 °C.
Determination of Lysozyme Activity:
Lysozyme, grade I, from egg whites, was assayed by a modified procedure of Shugar 115 . The substrate, Micrococcus lysodeikticus (Sigma
Chemical Co., St. Louis, Mo.) was prepared by adding approximately 1.5 mg
~-

lysodeikticus to 10.0 mL of 0.066 mol/L potassium phosphate buffer, pH

6.24.

The absorbance of this solution was adjusted to between 0.6 and

0.7 at 450 nm with buffer.

Of this adjusted substrate suspension, 0.625

mL was added to a micro silica cuvette.

To this was added 0.1-0.2 mL of

either buffer or prepared antisera and mixed.

Finally, 0.1 mL of a ly-

sozyme solution or lysozyme-desmosine or isodesmosine conjugate solution
(1.0 mg lysozyme or lysozyme conjugate dissolved in 10.0 mL of 0.066

mol/L potassium phosphate buffer, pH 6.24) was added and quickly mixed
by inversion.

Following an initial equilibration period of between 15

and 120 seconds, the absorbance at 450 nm (A 450 ) was recorded every 30
seconds. The A450 was recorded for a period of 2 to 4 min following the
initial equilibration, and the relative rate, A450 change/min (6A450 ) was
determined.
This assay was utilized to determine the rate of the reaction for
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unconjugated and the conjugated enzyme, as well as for titering the antisera for the quantitation of the desmosines.
Determination of Glucose-6-Phosphate Dehydrogenase Activity:
Glucose-6-phosphate dehydrogenase activity was assayed by a modified
procedure of Bergmeyer et al 116 . The activity was determined by the
change in absorbance at 340 nm.

The assay was as follows: 2.95 ml of a

0.1 mol/L Tris buffer, pH 7.6, containing 6.9 mmol/L magnesium chloride,
1.0 mmol/L glucose-6-phosphate, and 0.39 mmol/L nicotine adenine dinucleotide phosphate (NADP) was added to a 3.0 ml cuvette.

At time zero,

0.02 ml of a glucose-6-phosphate dehydrogenase (G-6-PDase) solution (2.05
mg protein/ml buffer) was added to the sample cuvette and mixed.

The re-

ference cuvette contained 2.92 ml of 0.1 mol/L Tris buffer, pH 7.6, containing the various cofactors.

The absorbance at 340 nm was recorded for

a period of 5 min and the relative rate, A340 change/min was determined.
This assay was utilized to determine the rate of the reaction for
the unconjugated and the conjugated enzyme for the quantitation of the
desmosines.
Production of Antibodies to Desmosine and Isodesmosine:
Various amounts of lyophilized BSA-desmosine or BSA-isodesmosine
conjugates (2.5 to 5.0 mg) were dissolved in a minimal amount of sterile
normal saline.

An equal volume of Freund•s complete adjuvant was added

and the mixture was emulsified by repeatedly aspirating and expelling the
mixture from a sterile glass syringe fitted with a 21 gauge needle 117
A frothy white appearence indicated complete emulsification.
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The emulsified mixture was administered by a modified method of Vaitukaitis et al 117 . The fur was shaved from the back and proximal limbs
of New Zealand white rabbits, and the emulsion was injected intradermally
at 15 to 20 sites, such that each rabbit received a total of 2.0 mL.
Following the initial inoculation, booster injections of from 2.5
to 5.0 mg of emulsified conjugates (Freund•s incomplete adjuvant) were
administered intramuscularly bi-weekly. After 8 weeks the rabbits were
bled 117 . Bleeding was accomplished via the central ear artery, following the shaving of the ear and application of xylene for vasodilitation.
The blood was collected into sterile 10 ml glass syringes, and transferred to silicone coated vacutainers.
from each rabbit per bleeding.

Two to 4 ml of blood was collected

After clotting and centrifuging, the

sera were frozen in 1.0 ml aliquots.

Booster injections were continued

throughout the course of bleeding the rabbits.
During the course of these procedures, the rabbits were housed at
the animal research facility, Loyola University Medical Center, and fed
standard lab chow and allowed water ad lib.
Titering of the Antisera:
The antisera collected from the rabbits were diluted 1:1, 1:10,
1:100, and 1:1000 with either 0.066 mol/L potassium phosphate buffer,
pH 6.24, or 0.1 mol/L Tris buffer, pH 7.6 to be used in the lysozyme or
G-6-PDase assays, respectively.

The various dilutions were then added to

their respective assays, as previously described, and the relative rate
of the reaction calculated for each.
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3H-Isodesmosine Conjugation to BSA:
To 24.0 mg of unlabeled isodesmosine, approximately 0.5 ml of 3Hisodesmosine (0.02 mg;
IL.) was added.

~100 ~Ci),

prepared by Amersham (Arlington Heights,

This mixture was then conjugated to BSA as previously

described with an isodesmosine to BSA ratio of 60 and a glutaraldehyde to
isodesmosine ratio of 1.

Following its lyophilization, the conjugate was

dissolved in a minimum amount of glass distilled, deionized water.

To

this was added 8.0 mL of scintillation fluor (4% PPO, 10% BSS, toluene,
w/v) and the conjugate was counted to a 0.2% error in a Beckman scintillation counter.
HPLC DETERMINATIONS
All HPLC determinations for desmosine or isodesmosine utilized a
Water•s M-6000 pump system connected to a Water•s U6K injector fitted
with a 2.0 ml injection loop.

The amino acids were detected with either

a Water•s M-440 dual wavelength detector (254 and 280 nm) or a Water•s
M-450 variable wavelength detector at 205 nm, or a Water•s M-420 fluorescence detector (334 nm excitation, 450 nm emission).

An Omniscribe

dual pen recorder was utilized to quantitate the various amino acids as
they eluted via the peak height method.
Hamilton 50

~L

All injection were made with a

syringe, designed for the Water•s injector.

Ion-Exchange HPLC:
For all ion-exchange determinations, a Whatman SCX/Partisil 10, 25 x
0.4 em column was utilized.

The column consisted of sulfonic acid func-

tional groups bound to inert particles 10

~m

in size.

For determina-
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tions the amino acids were first dissolved in 0.1 mol/L potassium hydroxide (10 mg amino acid/50 ml).

Five

~L

of each were injected onto the

column and eluted with 0.2 mol/L ammonium phosphate (dibasic) buffer,
with the pH varied from 2.5 to 3.5.

The mobile phase was maintained at

a constant flow of 0.7 ml/min (300 psig).

The amino acids were detected

at either 280, 245, or 205 nm as they eluted from the column.
Reverse Phase and Ion-Suppression HPLC:
For all reverse phase and reverse phase-ion suppression HPLC determinations a Water's C-18
column was utilized.

~-Bondapak

30.0 x 4.0 mm, 10

~m

particle size,

This column consists of octadecyl alkane moieties

chemically bonded to silica particles.

The amino acids were separated
and quantitated by a modified method of Hancock 104 . In this procedure,
5 to 10

~L

of the amino acid solutions (10 mg amino acid/50 ml water)

were injected onto the column and eluted with a mobile phase, which consisted of a methanol/water/phosphoric acid solution, which varied from
0/99/1 to 40/59/1 (v/v).

The pH varied from 2.5 to 6.0.

The flow rate

was maintained at 1.0 mL/min (1800 to 2500 psig, depending on the methanol percentage of the mobile phase).

The amino acids were detected at 205

nm as they eluted from the column.
Derivatization with ortho-Phthaldialdehyde:
The methods of Lindroth and Mop per 105 , and Gardner and ~·1i 11 er 106 ,
were employed for the derivatization and detection of the amino acids.
The method utilized a pre-column derivatization procedure prior to the
injection of the amino acids onto the C-18 column.

Again a Water's C-18

column was utilized.
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The amino acids were derivatized with o-phthaldal-

dehyde (OPA) reagent, which consisted of 270 mg OPA (Sigma Chemical Co.,
St. Louis, Mo.) dissolved in 5.0 mL of absolute ethanol.
added 200

~L

of 2-mercaptoethanol.

To this was

The OPA reagent was then made to 500

mL with 0.4 mol/L boric acid, pH 9.5.
To derivatize the amino acids, 100
~L

Ten

~L

of OPA reagent was added to 20

of the sample, and allowed to react at room temperature for 2.0 min.
~L

of the derivatized sample was then injected onto the column and

eluted with 0.05 mol/L sodium phosphate (monobasic) buffer, pH 7.3, with
the methanol percentage varied between 50

~nd

95%.

The mobile phase was

maintained at a constant flow of 1.0 mL/min, and the amino acids were
detected as they eluted from the column by fluorescence, at an excitation
wavelenth of 340 nm and an emission wavelength of 450 nm.
Ion-Paired HPLC:
This method of separation (PIC R Supplement, Water•s Inc.) utilized
the sodium salt of heptane sulfonic acid (Eastman Kodak Co., Rochester,
N.Y.) as the counter ion.

For separation of the desmosines, this system

employed either a Water•s C-18 column as previously described or a BioRad ODS-5, 15 em x 4 mm i.d., C-18 column (5

~m

particle size).

The

amino acids either from standards or from hydrolysates were eluted with
a methanol/water solvent, with the methanol percentage varied between 19
and 30%.

'

The solvent contained 0.01 mol/L heptane sulfonic acid, sodium

salt, and was adjusted to pH 3.0 with phosphoric acid.

The mobile phase

was maintained at a constant flow of 1.0 mL/min (1000 to 2500 psig, depending on the methanol percentage in the mobile phase).

The eluted
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amino acids were detected at either 205, 254, or 280 nm and were quantitated by peak height, as compared to a standard curve.
Tissue Preparation:
Tissue samples from both canine and human aortas were first cleaned
by removing any plaque and fat deposits which were visibly present.

The

tissue was minced and weighed to yield a wet weight of from 2 to 4 g.
The minced tissue was then dried at 60 °C at 0.05 mm Hg pressure overnight to a constant weight.

The dried tissue was then defatted by a

series of ethanol, ethanol-ether (1:1), and finally ether extractions.
The tissue was again dried and weighed to yield a fat free dry weight
(FFDW).
The FFDW tissue was then hydrolyzed at 110 °C for 48 hours with 6
mol/L hydrochloric acid.

Following hydrolysis, 20 to 30 mg of activated

charcoal was added to the hydrolysate and the mixture was again heated to
60 °C with agitation for 10 min, followed by filtering through a 3 ~m
Millipore filter to remove the charcoal.
For amino acid analysis by the Beckman 121 C, the hydrolysate was
diluted with 0.2 mol/L sodium citrate buffer, pH 2.2, and analyzed as
previously described.

For analysis by HPLC, the hydrochloric acid had

first to be removed.

This was accomplished by a series of washings with

water, each followed by evaporation under vacuum.

Once the hydrochloric

acid was removed, the hydrolysate was diluted to final volume with glass
distilled, deionized water.
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RECOVERY STUDIES OF THE DESMOSINES USING HPLC
Recovery from Hydrolyzed BSA:
To determine the analytical recovery and to check the linearity of
the ion-paired HPLC method, desmosine and isodesmosine were added to BSA,
prehydrolysis.

In this method, 50 mg of BSA was added to consecutively

numbered hydrolysis tubes.
sine was added.

To the first tube, no desmosine or isodesmo-

To the remaining tubes, desmosine and isodesmosine were

added in various amounts to achieve the following concentrations: Tube 2,
0.0224 and 0.0130 mmol/L; tube 3, 0.0448 and 0.0180 mmol/L; tube 4,
0.0597 and 0.0265 mmol/L; and to tube 5, 0.0784 and 0.0397 mmol/L, desmosine and isodesmosine, respectively.

The BSA was then hydrolyzed as pre-

viously described, followed by the determination of the desmosines.
Recovery from Hydrolyzed Canine Aorta:
The above recovery studies were then repeated substituting prepared
canine aorta for the BSA.

Once the initial desmosine and isodesmosine

concentration of the aorta sample was determined, the remaining tissue
was spiked {prehydrolysis) with desmosine and isodesmosine to achieve the
following concentrations of desmosine and isodesmosine, respectively:
0.056 and 0.049 mmol/L; 0.060 and 0.056 mmol/L; 0.070 and 0.061 mmol/L;
0.072 and 0.066 mmol/L; and finally 0.080 and 0.078 mmol/L.

The spiked

aorta samples were then hydrolyzed and the desmosine and isodesmosine
concentrations determined, as previously described.
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COLLAGEN DETERMINATIONS
Hydroxyproline Determinations:
The collagen content of all the tissue hydrolysates was determined
by the method of Blumenkrantz and Asboe-Hanson 40 In this method, the
hydroxyproline content is correlated to the amount of collagen present in
the tissue.

For this method, 1.0 mL of hydrolysate was mixed with 1.5 mL

of a borate-alanine buffer, pH 8.7 and 600 uL of a 0.2 mol/L chloramine T
solution.

Following a 20 min reaction time, 2.0 mL of a 3.6 mol/L thio-

sulfate solution was added and throughly mixed.
added to the mixture to saturation levels.

Sodium chloride was then

After a 20-30 minutes, 3.0

mL of toluene was added to the.tube , followed by heating at 100 °C in a
water bath.

The tubes were then cooled and allowed to set for 15 min

followed by a slow speed centrifugation for 10 min.
One mL of the organic layer was then removed and mixed with 0.4 ml
of Ehrlich's reagent (Appendix A).

After a 30 min reaction time in the

dark, at room temperature, the solution was read in a spectrophotometer
at 565 nm against a reagent blank.
curve for hydroxyproline.

The A565 was compared to a standard

CHAPTER 4
RESULTS
PURIFICATION OF THE DESMOSINES
From the amino acid analysis of the commercially prepared desmosine
and isodesmosine, it was observed that mutiple unknown peaks appeared on
the aminograms.

Since the desmosines would be used in the conjugation

reactions, it was decided that they should be further purified.

The des-

mosines were then purified as described in Chapter 3.
Two criteria were used to judge the purity of the desalted, purified
desmosines, the first being a single eluting peak on amino acid analysis,
and secondly a comparison of their respective ultra-violet (UV) spectra
to those published.

Following their purification, desmosine and isodes-

mosine were both found to elute as single peaks on amino acid analysis,
at 70 and 78 min, respectively, devoid of any extraneous peaks first observed on amino acid analysis of the unpurified desmosines (Figs. 5,6).
These purified fractions were then subjected to UV analysis, as previously described.

Both desmosine and isodesmosine were found to display UV

absorption in the 200 to 280 nm range, desmosine displaying its characteristic bi-modal absorption spectrum, having absorbance maxima at 238
and 268 nm, with a slight inflection at 273 nm (Fig. 7), while isodesmosine displaying its characteristic single absorption maximum at 278 nm,
with an inflection at 217 nm (Fig. 8).

Both these obtained spectra correlated well with those previously published 8 , 9
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Therefore, from the results obtained from amino acid analysis and UV analysis, it was determined that the desmosine and isodesmosine preparations
were pure.

The purified desmosine and isodesmosine, hereinafter referred

to as desmosine and isodesmosine, were used in the conjugation and antibody production phase of the research, as

\'le

11 as for the standards in

all automated amino acid analysis and HPLC method development.
CONJUGATION AND ANTIBODY PRODUCTION
Purification of Glutaraldehyde:
In order to elicit an antigenic response from the inoculated rabbits, desmosine or isodesmosine first had to be conjugated to a carrier
molecule, BSA fraction V.

It was decided that this conjugation of either

Des or Ide to BSA should be attempted via a reaction with glutaraldehyde.
However, before attempting this conjugation, the commercially prepared
25% glutaraldehyde was purified.

This purification involved the stirring

of the glutaraldehyde solution with activated charcoal, as described in
Chapter 3.

According to the literature, an absence of an absorbance

peak at 235 nm, as well as the solution being clear and colorless with a
distinct "fruity" fragrance, are all indicative of a pure solution 109 .
In the commercially prepared solution of glutaraldehyde, a strong absorption peak was noted at 235 nm and the solution had a yellowish tinge.
However, on treatment with activated charcoal, the filtrate was observed
to be clear and colorless, with a "fruity" fragrance.

The purified so-

lution also did not display any absorption peak at 235 nm.

Using the

before mentioned criteria, it was determined that the glutaraldehyde
solution was pure and suitable to be utilized in the conjugation reac-
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tion.
Conjugation of the Desmosines to BSA:
Following the purification of the desmosines, and the glutaraldehyde
solution, conjugation of either Des or Ide to BSA was attempted, as previously described in the methods.

In all conjugation studies the mol

ratio of Des or Ide to BSA was maintained at 60:1, with the mol ratio of
glutaraldehyde to Des or Ide varied from 1:1 to 10:1.
During the course of the conjugation reaction, it was noted that the
mixture changed from a clear, colorless solution to a straw yellow color,
and that a white flocculant precipitate formed.

Upon completion of the

reaction, the solution was placed on a Sephadex G-50 column, and eluted
with the appropriate buffer.

The eluant was monitored at 280 nm and 2

peaks were observed (Fig. 9).

The first peak eluted with the void vo-

lume, while the second eluted at approximately 60 ml.

The first peak was

found to contain the protein portion of the reaction, while the second
peak contained the unconjugated Des or Ide.
titate the unconjugated Des or Ide.

No attempt was made to quan-

The white flocculant precipitate

which formed was thought to be protein-protein macroconjugates, which
form as a side reaction to the conjugation process 114 .
Following the initial conjugation, the glutaraldehyde (Glu) to Des
ratio was varied from 1-10.

In these conjugation reactions, the appear-

ence, color and the amount of precipitation was qualitatively noted.
Finally, the amount of protein remaining in the supernatant, following
the 1,000 x

~centrifugation,

was quantitated by the Lowry method.

Table 5 shows the results of the various conjugation conditions uti-
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Fig.

9.

Elution profile of conjugation reaction mixture applied
to a Sephadex G-50 column, and eluted with 0.1 mol/L
sodium acetate buffer, pH 5.0. BSA-Desmosine conjugate
and unreacted desmosine detected at 280 nm.
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TABLE

5

DETER,"1INATION OF GLUTARALDEHYDE TO DES~10SINE RATIO
IN BSA-DESMOSINE CONJUGATION

GLU/DES

APPEARANCE*

AMOUNT
PRECIPITATION**

0

CLEAR

NONE

48 MG

1

liGHT YELLOW

SLIGHT

46 MG

2

STRAW YELLOW

~10DERATE

40 MG

3

YELLOW

MODERATE-HEAVY

20 MG

4

YELLOW

HEAVY

0 MG

PROTEIN***

DETERMINATION OF GLUTARALDEHYDE TO DESMOSINE RATIO FOR CONJUGATION OF
DESMOSINE TO BSA,

RATIOS ARE MOLAR AND BASED ON A DESMOSINE TO BSA

60 USING 50 MG OF BSA IN THE REACTION,
APPEARANCE OF REACTION MIXTURE FOLLOWING 3 HR, AT ROOM TEMPERATURE,

RATIO OF

•
••

RELATIVE AMOUNT OF PRECIPITATE FOLLOWING CENTRIFUGATION,

*** PROTEIN REMAINING IN SUPERNATANT FOLLOWING CENTRIFUGATION,

ized to determine the optimum glutaraldehyde to Des or Ide ratio.
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It was

noted that as the glutaraldehyde to Des ratio was increased from 1 to 4,
the amount of protein precipitation increased, with a concomitant decrease in the amount of protein remaining in the supernatant. It was also
observed that during the course of the reaction, the appearance of the
mixture changed from a colorless solution to a dark yellow, the color dependent on the glutaraldehyde to Des ratio.
From these findings, it was determined that all conjugation reactions would utilize a glutaraldehyde to Des or Ide ratio of 1 in order
to assure a maximum yield of conjugate (protein remaining in the supernatant) with a minimum of precipitation.
Conjugation of the Desmosines to Lysozyme or G-6-PDase:
Des or Ide was conjugated to lysozyme and G-6-PDase as previously
described in the methods.

The glutaraldehyde to Des or Ide ratio was

maintained at 1 (as determined in their conjugation to BSA) in order to
minimize any protein-protein macrocomplexes, which would decrease the
amount of available enzyme.

No visible precipitation was noted upon the

completion of the conjugation reaction; however, following the centrifugation, a minute amount of a white precipitate was noted.
In order to determine the loss of lysozyme activity due to the conjugation procedure, unconjugated lysozyme activity was compared to that
of the lysozyme-Des or -Ide conjugate.

When the two were normalized to

mg protein, a substantial decrease was noted in the conjugated enzyme
(9.05 ± 0.16

~A/min/mg

vs. 1.37 ± 0.07

~A/min/mg,

respectively).

This

decrease amounts to a loss of approximately 85% of the unconjugated lyso-
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zyme activity. This loss, however, was not unexpected, as loss of enzyme
activity upon conjugation has been reported 110 , 111 , 113 Even with the
85% loss of activity, it was decided that the remaining activity should
be sufficient for the quantitation of the desmosines utilizing lysozyme.
Glucose-6-phosphate dehydrogenase activity was also compared between
the unconjugated and conjugated enzyme.
normalized to units of activity.

In these assays the rates were

Upon normalization, it was found that

51% of the unconjugated enzyme activity was lost due to the conjugation
process (2.05 ± 0.04 6A/min/unit vs. 1.23 ± 0.06 6A/min/unit).
Of the two enzyme assays, there was a greater sensitivity, as well
as a greater yield of active enzyme, with G-6-PDase.

However, both en-

zymes were utilized to titer the antisera, in order to determine which
enzyme was better suited for the quantitation of the desmosines.
Antibody Production:
Bovine serum albumin-desmosine or isodesmosine conjugates were injected into New Zealand white rabbits as previously described.

A total

of 8 rabbits (4 groups) were inoculated with either 2.5 or 5.0 mg conjugate/injection.

Rabbits 1 and 2 recieved 2.5 mg BSA-Des conjugate/injec-

tion, while rabbits 3 and 4 received 5.0 mg BSA-Des conjugate/injection.
Rabbits 5 and 6, and 7 and 8, were injected with 2.5 and 5.0 mg BSA-Ide
conjugate/injection, respectively.
Following the initial inoculations, lesions developed at the sites
of the injections.

These lesion eventually cleared, and no other gross

problems were encountered during the course of the antibody production.
The initial bleeding of the rabbits occurred after 8 weeks, and was

59

continued every 2 weeks thereafter, up to 16 weeks.

Booster injections

were administered every 2 weeks, with Freund•s incomplete adjuvant, and
continued throughout the 16 weeks.
The antisera collected from each bleeding were diluted to various
titers {1, 1:1, 1:10, 1:100, 1:1000) with buffer used for each enzyme.
These various titers were then assayed for antibody activity utilizing
both the Des or Ide conjugated lysozyme or G-6-PDase preparations.

If

antibody activity was present, then a decrease in enzyme activity {rate)
from the control activity {sera from untreated rabbits) should be observed.

When the various antisera obtained from the rabbits over several

bleedings were assayed, no decrease in either enzyme activity from control values were noted (Tables 6-9).
final bleeding at 16 weeks.

The specific data shown is for the

No differences were noted between the rab-

bits in each group, or the time interval from the initial inoculations.
It was noted that the enzyme activity substantially increased when any
serum (both control and antiserum) was added to the assay mixture.

This

increase is thought to be due, in part, to non-specific activation of
the enzymes by the proteins or the co-factors present in the serum of
the rabbits.
The lack of inhibition of either enzyme assayed, at the various
titers of the antisera, could be accounted for by several reasons.

One,

that the assays were not sufficiently sensitive enough to detect the decrease in the activity {rate) of the enzymes, or two, that antibodies to
either Des or Ide were not produced.

Since both enzymes employed in this

research have been extensively utilized in this type of assay, it was
decided to investigate the possibility that antibodies were not being
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TABLE 6
TITERING OF DESMOSINE ANTISERA
FROM RABBIT 1

TITER OF
ANTISERA

LYSOZYME
(liA/MliM·1G PROTEIN)

G-6-PDASE

0*

1.36 :t 0.07

1.22 :t 0.05

1

1.66 :t 0.03

1.52 ± 0.04

1:1

1.69 :t 8.04

1.?1 ± 0.03

1:10

1. 67 ± 0. 03

1.49 ± 0.06

1:100

1.65 ± 0.02

1. 53 ± 0.02

1:1000

1.68 ± 0.03

1.50±0.03

CONTROL**

1.63 :t 0.05

1.53 ± 0.04

CM/MIN/UNIT)

RATE OF REACTION FOR LYSOZYME- AND G-6-PDASE-DESMOSINE CONJUGATES
AT VARIOUS TITERS OF ANTISERA FROM RABBIT

1.

ADMINISTERED 2.5 MG BSA-DESMOSINE CONJUGATE/INJECTION,
* ASSAYED WITH APPROPRIATE BUFFER, REPLACING ANTISERA,
**ASSAYED WITH SERA FROM UNTREATED RABBIT,
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TABLE 7
TITERING OF DESMOSINE ANTISERA
FROM RABBIT 3

ANTISERA

G-6-PDASE

LYSOZYME

TITER OF

<~A/MIN/MG

(t.A/MIN/UNIT)

PROTEIN)

'

0*

1. 36 :!: 0. 07

1.22 :!: 0.05

1

1.69 :!: 0.05

1.54 :!: 0.05

1:1

1.65 :!: 0.03

1.58 :!: 0.04

1:10

1.67:!: 0.03

1.58 :!: 0.06

1:100

1.68 :!: 0.04

1.56 :!: 0.02

1:1000

1.65:!: 0.03

1.52 :!: 0.03

CONTROL**

1. 66 :!: 0.06

1.52 :!: 0.04

RATE OF REACTION FOR LYSOZYME- AND G-6-PDASE- DESMOSINE CONJUGATES
AT VARIOUS TITERS OF ANTISERA FROM RABBIT

1.

ADMINISTERED 5,0 MG BSA-DESMOSINE CONJUGATE/INJECTION

* ASSAYED WITH APPROPRIATE

BUFFER~ REPLACING ANTISERA.

** ASSAYED WITH SERA FROM UNTREATED RABBIT,
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TABLE 8
TITERING OF ISODESMOSINE ANTISERA
FROM RABBIT 5

G-6-PDASE
(6A/M1N/UNIT)

TITER OF
ANTISERA

LYSOZYME
(6A/MIN/MG PROTEIN)

o·

1.36 ± 0.07

1.22 ± 0.05

1
1:1
1:10
1:100
1:1000

1. 64 ± a. 03

1.45 :!: 0.04
1.43 :!: 0.07
1.48 :!: 0.06
1. 45 :!: 0.03
1.44:!: 0.04
1.46 ± 0.03

± 0.04
:!: 0.05
± 0.03
:!: 0. 04
1.64 :!: 0.02

1.67
1. 60
1.65
1. 63

CONTROL**

RATE OF REACTION FOR LYSOZYME- AND 6-6-PDASE-ISODESMOSIN~
CONJUGATE AT VARIOUS TITERS OF ANTISERA FROM RABBIT
ADMINISTERED

2.5

5,

MG BSA-ISODESMOSINE CONJUGATE/INJECTION,

* ASSAYED WITH APPROPRIATE BUFFER1 REPLACING ANTISERA,

**

ASSAYED WITH SERA FROM UNTREATED RABBIT,
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TABLE 9
TITERING OF ISODES~10SINE ANTISERA
FROM RABBIT 7

TITER OF
ANTISERA
0*

1
1:1

LYSOZYME
(~A/MIN/MG PROTEIN)
1.36 ± 0.07
1.56 ± 0.05

1:10
1:100
1:1000

1. 50
1.55
1.52
1.50

±
±
±
:t

0. 04
0.06
0.05
0.03

CONTROL**

1.53 ± 0.04

G-6-PDASE
( M/MIN/UN IT)
1.22
1.40
1.38
1.42
1.40
1.41

± 0.05
± 0.03
± 0.04
± 0.02
± 0.05
:t 0.03

1.40 ±. 0.06

RATE OF REACTION FOR LYSOZYME- AND G-6-PDASE-ISODESMOSINE
CONJUGATES AT VARIOUS TITERS OF ANTISERA FROM RABBIT 7,
ADMINISTERED 5,0 MG BSA-ISODESMOSINE CONJUGATE/INJECTION

* ASSAYED WITH APPROPRIATE BUFFER, REPLACING ANTISERA,

** ASSAYED WITH SERA FROM UNTREATED RABBIT,
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produced to either Des or Ide.
Immunodiffusion Studies:
In order to determine if in fact antibodies were being produced to
the desmosines, immunodiffusion studies were undertaken.

In this tech-

nique, six wells are punched in a 1% agarose gel film, in a hexagonal
shape, with a seventh well punched in the center of the hexagon. The
antisera is placed in the center well, while the antigens are placed in
the surrounding wells.

As the solutions diffuse through the agarose,

they eventually interface with each other.

At the interface between the

antisera and its specific antigen, a precipitin band will be observed,
due to the antigen-antibody complex which is formed.
In this study, prepared immunodiffusion plates {Travenol, 1% agarose, containing 0.1% sodium azide to retard bacterial growth) were utilized.

The various titers of each antisera were placed into the center

well, while the outer wells contained solutions of the various possible
antigens.

To one well, a 10% solution of BSA was added, while to another

well, either BSA-Des or BSA-Ide was added, depending on the antisera in
the center well.

To the third well, the corresponding G-6-PDase-Des or

-Ide conjugate was added.

Finally the corresponding lysozyme-Des or

-Ide conjugate was added.

The plates were allowed to incubate at 5 °C

for periods up to 1 week, with daily observation.
It was observed that precipitin bands formed at all titers investigated (1:1, 1:10, and 1:100, antisera in 0.9% sterile saline) to the 10%
BSA solution, as well as the BSA-conjugates, within 1 days incubation.
No precipitin bands were observed between the antisera and the corres-
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pending enzyme conjugates by the end of the fifth day.
In order to determine if the two buffers utilized in the enzyme
assays had an effect on the antigen-antibody complex formation, the experiment was repeated using the corresponding enzyme buffers in lieu of
the 0.9% sterile saline solution used to prepare the various titers of
the antisera.

The results were essentially the same, precipitin bands

were formed between all titers of the antisera to the BSA solution or
the BSA-conjugates.

Again, however, no precipitin bands were observed

between the antisera and its respective enzyme conjugate.
In both of the immunodiffusion studies, untreated rabbit sera was
run as a control, and in all cases, no precipitin bands were formed between any of the solutions during the 5 day incubation preiod.
From these results it was concluded that antibodies were being produced to BSA, however, no evidence existed that antibodies to enzyme
conjugates were being produced.

These results implied that antibodies

to Des or Ide were not being produced by the rabbits.
Conjugation Studies:
The results from the previous study, i.e., the production of antibodies to BSA, while no apparent antibody production to Des or Ide, could
be explained by the failure to conjugate the desmosines to the BSA molecule.

This occurence would also explain the large amount of unreacted

Des or Ide eluted from the Sephadex G-50 column following conjugation.
Therefore, in order to determine if this situation existed, Des was conjugated to BSA in the manner previously described, maintaining the Des to
BSA ratio of 60, and varying the glutaraldehyde to Des ratio from 0 to 4.
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Following the conjugation reaction, the conjugate was separated into its
two fractions via gel filtration, both fractions being collected.

The

first fraction (presumptive conjugate) plus any precipitate formed during
the conjugation reaction was collected and hydrolyzed as previously described.

The hydrolysates were then analyzed for their amino acid com-

position, as was the second fraction eluted from the column.

Table 10

displays the results from these studies, and as can be observed, no Des
was detected in the first fraction at any of the Glu to Des ratios investigated, and that the amount of Des recovered from the second fraction
did not significantly differ from the control reaction (Glu to Des

= 0).

From these results it was concluded that Des or Ide, in amounts
capable of being detected by automated amino acid analysis, were not
being conjugated to the BSA molecule at the glutaraldehyde to Des or Ide
ratio utilized in the initial preparation of the conjugates.
3H-Isodesmosine Conjugation Study:
In the event that the amino acid analyzer was not sensitive enough
to detect the amount of Des or Ide being conjugated to the BSA molecule,
a radiolabeled tracer ( 3H-isodesmosine) was utilized in a conjugation reaction.

The labeled isodesmosine was reacted with the BSA as described
in the methods, and following the conjugation, the amount of 3H-label in-

corporated into the BSA molecule was determined by liquid scintillation
counting.
At a glutaraldehyde to Ide ratio of 1, the ratio employed in the
initial conjugation reactions, no activity above background could be
detected in the first fraction off the column, while the second fraction
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TABLE 10
DESr10SINE CONJUGATED TO BSA AT
VARIOUS GLUTARALDEHYDE TO DESMOSINE PATIOS

DES RECOVERED ***

GLU/DES

MOLE DES/f·10LE BSA

CONTROL*

0

0**

0

0.043 MMOLE

1

0

0.043 MMOLE

2

0

0.042 MMOLE

3

0

0.043 MMOLE

0

DETERMINATION OF THE AMOUNT DESMOSINE CONJUGATED TO BSA AT VARIOUS
GLUTARALDEHYDE TO DESMOSINE RATIOS BY METHOD PREVIOUSLY DESCRIBED,
DESMOSINE DETERMINED BY AMINO ACID ANALYSIS,

.

fiFTY MG BSA HYDROLYZED AND ANALYZED,

••

As IN CONJUGATION REACTION WITHOUT ADDITION OF GLUTARALDEHYDE,

....

DETERMINED FROM DESMOSINE FRACTION FROM SEPHADEX

G-50 COLUMN •
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collected contained significant activity.
From this qualitative study, when combined with the other conjugation studies, it was determined that at the glutaraldehyde to Des or Ide
ratio utilized in this project, the two derived amino acids were not
being conjugated to BSA, and consequently not producing antibodies.
HPLC STUDIES
Due to the inability to produce antibodies for use in an EIA for
the desmosines, alternative methods of quantitation were investigated.
These methods utilized high performance liquid chromatography, specifically, ion-exchange, reverse phase, reverse phase with ion suppression,
and ion-pairing for the separation and quantitation of the desmosines.
Ion-Exchange HPLC:
The first technique investigated for the separation and quantitation
of the desmosines was ion-exchange HPLC, due to its similarity to automated amino acid analysis (AAA).

However, in contrast to AAA, which uses

several buffers to elute the amino acids, this HPLC system uses only one
buffer to elute all the amino acids (isocratic).
Initial attempts to separate the desmosines from the other amino
acids used a system which consisted of 0.2 mol/L ammonium phosphate buffer, pH 3.5, with the eluted amino acids detected at either 205 or 254
nm.

A representitive chromatogram of an amino acid standard containing

Trp, Phe, and Des is shown in Fig. 10.

With this system, the 3 amino

acids separated from one another, Trp eluting first, followed by Phe and
Des.

However, when a mixture of Des and Ide was injected, the two amino
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nnin.

Fig.

10.

Cation exchange HPLC separation of amino acid
standard containing Trp, Phe, and Des. Standards eluted with 0.2 mol/L ammonium phosphate
buffer, pH 3.5, and detected at 254 nm.
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TABLE 11

K'

VALUES OF VARIOUS AMINO ACIDS AT PH

3,5

2.5

AND

USING ION-EXCHANGE HPLC

ArliNO ACID

3.5

••

ALA

**

TRP

0.52
••
••
0.90
1.50
1.50

lLE
PHE

DEs
IDE

PH

K'

TYR

LEU

K'

PH

2.5

K'
0.25
0.28
0.68
1.03
1.03
1.21
1.97
1.97

DETERMINED FOR VARIOUS AMINO ACIDS USING JON-EXCHANGE HPLC ANALYSIS

WITH A MOBILE PHASE OF

2.5, WITH A FLOW RATE
AT 205 AND 254 NM,

0.2 MOLfL AMt-IONIUM PHOSPHATE BUFFER, PH 3.5 AND
OF 0.7 MLIMIN (300 PSIG), AMINO ACIDS DETECTED

* TEN MG OF AMINO ACID DISSOLVED IN 50 ML OF
INJECTION VOLUME OF

•• Nor

DETERMINED,

5 pl.

0.01

MOLIL KQH.

71

acids failed to separate.

This result was further verified by injecting

single amino acid standards of Trp, Phe, Des, and Ide, and determining
their respective k' values.

The k' values for Trp, Phe, and Des; or Trp,

Phe, and Ide were sufficiently different such that they could be quantitated (Table 11).

However, the k' values for Des and Ide were identical,

making it impossible to accurately quantitate them in a mixture.
In an attempt to separate the desmosines, the pH of the mobile phase
was lowered to 2.5, and again a series of amino acid standards were injected.

With this modified system, the k' values of the amino acids in-

creased from those obtained initially, and other amino acids were now
resolvable (Tyr, Ala, Leu, or Ile).

However, Des and Ide were still un-

resolvable, as was Leu and Ile (Table 11).
From these results, it was concluded that although Des and Ide could
be separated from various other amino acids, it was not possible to separate the two utilizing either of the two isocratic elution schemes discribed.

These results were also confirmed by Farris and co-workers, when

they failed to separate Des form Ide utilizing a similar ion-exchange
system 118 .
Reverse Phase HPLC:
Since the desmosines were found to be unresolvable with either of
the isocratic, ion-exchange systems described, another separation technique was investigated.

Reverse phase HPLC encompasses 3 different me-

thods of separation, all of which rely on the interaction between the
organic characteristics of the analytes and the octadecyl (C-18) column.
The first method investigated utilized a system which would separate
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the desmosines without any enhancement of their organic nature.

This

system consisted of a methanol/phosphoric acid/water (30/1/69, v/v) buffer, pH 5.85.
nm.

The eluted amino acids were detected at either 205 or 254

A representitive chromatogram of a standard containing Des, Phe, and

Trp is shown in Fig. 11.

With this system the 3 amino acids were found

to elute in reverse order from the ion-exchange system (Des, Phe, and
Trp), and with sufficiently different retention times to facilitate their
quantitation.

However, it was noted that Des eluted with the void volume

of the column, and that when a mixture of Des and Ide was injected, they
both eluted with the void volume.

These results were indicative of no

interaction between the desmosines and the C-18 column (Table 12).
Since the desmosines were eluting unresolved with the void volume
of the column, it was attempted to increase their interaction with the
column by lowering the methanol percentage of the mobile phase to 10%.
This modification should allow for more hydrophobic interactions to
occur between the desmosines and the column.

It was found that while

this modification of the mobile phase did increase the k' values of the
other various amino acids, though not substantially, Des and Ide still
eluted with the void volume (Table 12).
Reverse Phase-Ion Suppression HPLC Studies:
With the failure to resolve the desmosines with a lowering of the
methanol percentage in the mobile phase, it was decided to decrease their
polarity by partially suppressing their ionic nature.

With this ion sup-

pression, the desmosines should interact with the C-18 moieties of the
column more effectively.

Therefore, the pH of the mobile phase was
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Fig.

11.

Reverse phase HPLC separation of amino acid standard
containing Trp, Phe, and Des. Standards eluted with
a mobile phase consisting of methanol/water/phosphoric
acid (30/69/1, v/v/v) and detected at 254 nm.
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TABLE 12
K' VALUES OF VARIOUS AMINO ACIDS
ELUTED WITH 30 AND 10 % r·1ETHANOL
USING REVERSE PHASE HPLC

N1!NO ACID*
DEs
IDE
PHE
TRP

30%

10%

K'

K'

0.00
0.00
0.66
1.11

0.00
0.00
0.72
1.20

K' DETERMINED FOR VARIOUS AMINO ACIDS USING REVERSE PHASE HPLC ANALYSIS
WITH A MOBILE PHASE OF METHANOL/PHOSPHORIC ACID/WATER

10/1/89, v/v), PH 5.35,
DETECTED AT 254 NM,

WITH A FLOW RATE OF

1

MLIMIN.

* TEN MG AMINO ACID DISSOLVED IN 50 ML OF WATER.
INJECTION VOLUME OF

5 pL.

(30/1/69 AND
AMINO ACIDS
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to 2.5, a pH at which several of the carboxyl functions on the desmosines

would be protonated, thereby decreasing their polarity.

To further en-

hance their interaction with the column, the methanol was entirely removed from the mobile phase.
Amino acid standards of Des, Ide, Phe, and Trp were then injected
and eluted with this modified mobile phase of water/phosphoric acid
(99/1, v/v), pH 2.5 (Table 13).

It was found that, though the k' values

of Phe and Trp did substantually increase, Des and Ide still eluted with
the void volume of the column.
From the results of the reverse phase and ion-suppression studies,
it was concluded that although the desmosines were found to separate from
other various amino acids using these particular systems, the desmosines
themselves were still unresolvable.
Reverse Phase with OPA Derivatization:
From the previous studies it was determined that the polarity of the
desmosines would have to be further reduced in order to achieve any type
of separation between the two.

One method which should substantially

decrease their polarity would be to chemically modify the molecule.

This

modification could be accomplished by derivatizing the desmosines with a
fluorogenic compound, such as OPA.

This derivatization would not only

enhance their interaction with the C-18 moieties, but also aid in their
detection by being fluorescent.
The OPA derivatized amino acids were initially eluted with a mobile
phase consisting of 0.05 mol/L sodium phosphate buffer/methanol (50/50,
v/v), pH 7.3, and detected by fluorescence emission at 405 nm.

A repre-
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TABLE 13
K' VALUES OF VARIOUS AMINO ACIDS
USING ION SUPPRESSION HPLC

A11 I NO AC ID*

K'

DEs

0.00
0.00
1.16
2.02

IDE

PHE
TRP

K'

DETERMINED FOR THE VARIOUS AMINO ACIDS USING REVERSE PHASE-ION

SUPPRESSION HPLC ANALYSIS, WITH A MOBILE PHASE OF WATER/PHOSPHORIC

(99/l, v/v), PH 2,5, AT A FLOW RATE OF 1.0 MLIMIN,
ACIDS WERE DETECTED AT 254 NM,
* TEN MG AMINO ACID DISSOLVED IN 50 ML OF WATER,
ACID

INJECTION VOLUME OF

5 pL.

THE AMINO
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sentative chromatogram of an amino acid standard is shown in Fig. 12.
It was found that several of the derivatized amino acids were resolvable from one another.

However, upon injection of derivatized Des or

Ide no peaks were detected.

It was initially thought that since the des-

mosines contained 4 amino groups available for derivatization with OPA,
they could be retained by the column longer than 30 min.

Therefore, it

was decided to increase the methanol percentage of the mobile phase to
70% in order to decrease their retention time.
Fig. 13 is a representative chromatogram of the same amino acid
standard as previuosly injected, this time eluted with the modified mobile phase containing 70% methanol.

~·lith

this modification it was found

that all the derivatized amino acids eluted within 10 min, decreasing

.

their retention times by approximately one third.
and Ide were not detected.

Again, however, Des

Finally, the methanol percentage was increas-

ed to 90%, and the same amino acid standards injected.

With this in-

crease in the methanol percentage, it was found that all the amino acids
eluted within 1 min, yet Des and Ide were still undetected.
After reviewing the results from the derivatization method, it was
discovered that Des and Ide were eluting close to the void volume of the
column, and appeared as multiple peaks on the chromatogram.

Multiple

peaks could result from the 4 amino groups having different reactivities
with the OPA.

Similar results have been reported for dibasic amino acids
with OPA derivatization by Lindroth and r1opper 105 .
As the desmosines were found to elute in several fractions with the
OPA derivatization method, and as the desmosines were unresolvable using
the other reverse phase methods described, it was decided to attempt

78

40
minutes

Fig.

12.

Reverse phase HPLC separation of amino acid standard
containing His, Tyr, Leu, Ile, Phe, Arg, Lys, Ide,
and Des pre-derivatized with OPA. Standard eluted
with 0.05 mol/L sodium phosphate buffer/methanol
(50/50, v/v), pH 7.3, and detected by fluorescence
(340 nm excitation; 450 nm emission).
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13.

Reverse phase HPLC separation of amino acid standard
containing His, Tyr, Leu, Ile, Phe, Arg, Lys, Ide and
Des pre-derivatized with OPA. Standard eluted with
0.05 mol/L sodium phosphate buffer/methanol (30/70,
v/v), pH 7.3, and detected by fluorescence (340 nm excitation; 450 nm emission).
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their separation by ion-paired HPLC.
Ion-Paired HPLC:
Ion-paired HPLC utilizes a counter ion to one of the ionic species
present on the molecules to be separated 119 . It was decided to use a
counter ion to protonated amino groups which could be generated on the
desmosines.

This would require the mobile phase to be acidic, an en-

vironment suitable for the C-18 column.

The counter ion chosen for this

method was the sodium salt of heptane sulfonic acid, due to its widespread use in ion-paired systems, and its general availability 119 .
The concentration of the counter ion in most ion-paired systems vary
from 0.005 mol/L to 0.02 mol/L.

For this method of separation, knowing

that hydrolysates were to be used, it was decided initially to use a concentration of 0.01 mol/L.
Thus the ion-paired system utilized a methanol/water mobile phase,
containing 0.01 mol/L sodium heptane sulfonate at an acid pH. Initially,
a pH of 3 was used because at this pH several of the amino groups of the
desmosines were protonated.

Also, at this pH, minimal deterioration of

the column occurs (optimal pH range for C-18 columns is between 2.5 and
7.0) 12 , 119 . The eluted amino acids were detected at 205 nm, therefore,
the pH of the mobile phase was adjusted with phosphoric acid 104 .
With this system, it was found that many amino acids could be separated from one another, including the desmosines.

It was also found

that by varying the methanol percentage of the mobile phase, the retention times of the amino acids could be varied.

With this knowledge, it

was decided to use a methanol percentage which would yield minimum
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Thus in

retention times for the desmosines, yet allow their separation.

these preliminary studies, the methanol percentage of the mobile phase
was varied from 10 to 30%.
Initial attempts of the separation of the desmosines proved fruitful, in that it was found that the desmosines could be resolved using
this ion-paired system.

Finally, it was determined that by using a sys-

tem consisting of methanol/water (26/74, v/v), pH 3.0, containing 0.01
mol/L heptane sulfonic acid, baseline resolution of the two desmosines
could be achieved.

With this method, Ide and Des were found to elute at

57 and 62 min, respectively, having k 1 values of 50.80 and 57.33.
Once it was determined that the desmosines could be resolved, other
amino acids were investigated to determine if they would interfere.
These amino acids were then injected and their k values determined
1

(Table 14).

It was found that from this series of 25 amino acids, all of

which could possibly be present in the hydrolysates to be analyzed, none
eluted close to either Ide or Des, the closest being Trp with a k value
1

of 22.00.

Tryptophan, however, should be destroyed in the acid hydroly-

sis procedure, thereby separating the desmosines from the other amino
acids by approximately 30 min.
Once it was determined that the method would reproducibly separate
the desmosines from the other amino acids, the various chromatographic
constants (k•, a, Rs' and N) of the method were investigated (Table 15).
As previously described in Chapter 2, the capacity factor, k

1

,

measure of the retention of a particular solute by the system.

is a
Though

usually, in the interest of time, the k 1 values are kept below 10, in
the case of the desmosines, the k values were approximately 5 times
1
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TABLE 14

K'

VALUES FOR VARIOUS AMINO ACIDS USING ION-PAIRED HPLC

AMINO ACID

K'

HYDROXYLYSINE

0.56
0.76
0.81
1.10
1.12
1.25
1.30
1.30
1.35
1.42
1.44
3.40
5.96
6.36

LYSINE

6.92

TYROSINE

7.25
7.47
7.60
8.80
8.85
9.00
9.80
22.00
50.80
57.33

HYDROXYPROLINE
PROLINE
CYSTEINE
GLYCINE
ALANINE
GLUTAMIC ACID
GLUTAMINE
SERINE
THREONINE
AsPARTIc AcID
AsPARAGINE
VALINE
ORNITHINE

HISTIDINE
IsoLEUCINE
LEUCINE
ARGININE
NoRLEUCINE
PHENYLALANINE
TRYPTOPHAN
IsoDESMOSINE
DESMOSINE

k' values of various amino acid standards, calculated as
described in Chapter 2. Amino acids eluted with methanol/
water (26/74, v/v), pH 3.0, containing 0.01 mol/L heptane
sulfonic acid, and detected at 205 nm.
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TABLE 15
CHRONATOGRAPHIC CONSTANTS FOR DESMOSINE
AND ISODESMOSINE SEPARATION USING
ION-PAIRED HPLC

K'

N

Rs

IDE

DES

50.80

57.32

IDE
(HETP)*

4.80

1.13

29J026
(0.001)

DEs
(HETP)

25J600
(0.001)

VARIOUS CHROMATOGRAPHIC CONSTANTS DETERMINED FROM DES AND IDE
STANDARDSJ ELUTED WITH A MOBILE PHASE OF METHANOL/WATER
v/v)J PH 3.0J WITH A FLOW RATE OF

1.0

ML/MIN,

AMINO ACID DETECTION AT 205 NM,
CONSTANTS CALCULATED AS DESCRIBED IN CHAPTER

* HEIGHT EQUIVALENT TO THEORETICAL PLATES.

2.

(26/74J
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that value.

In an attempt to lower the k values for the desmosines
1

either by increasing the methanol percentage in the mobile phase, or by
adjusting the pH, the resolution of the two amino acids decreased.
Therefore, it was decided not to adjust the k values.
1

Although the k values of Des and Ide were higher than usual, the
1

separation factor, a, was found to be in an acceptable range.

This fac-

tor, as described in Chapter 2, is actually a measure of the relative retention of Des and Ide, and is related to the chemical parameters of the
method.

By definition, this factor should be greater than 1.00, and

since the factor utilizing this method of separation was greater than
1.3, modifications were not necessary 119 .
The efficiency (N) of the C-18 column to separate the desmosines was
found to be excellent, both having theoretical plate values exceeding
25,000.

Though these values are somewhat higher than those usually en-

countered in an HPLC method, this can be explained by the long retention
times of the desmosines and their relatively narrow peak width on elution
119
Another measure of the efficiency of the column to separate the
analytes is the height equivalent to theoretical plates (HETP), sometimes
abbreviated H 119 . This value is simply the column length in em divided
by the efficiency factor, N.

For this constant, the better the effi-

ciency, the lower the H value, just opposite to the definition for the
N factor.
Finally, the ability of this method to resolve the desmosines was
determined.

The factor, Rs, should be greater than 1 for quantitation,
and greater than 1.5 for baseline resolution 119 As described in
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Chapter 2, this factor takes into account all the other calculated constants determined for that specific system.

Thus, Rs is a measure of

the selectivity of the column for the analytes (as determined by the a
factor); secondly, it takes into account the efficiency of the column for
the analytes (as determined by theN factor); and thirdly, it takes into
account the capacity of the system for the analytes (as determined by

ki)·
Utilizing this method for the separation of the desmosines, the Rs
value was in excess of 4, indicating, for the amount of time on the column, the separation of the two eluted amino acids approached the baseline.

Thus, the desmosines should be able to be quantitated by this

method with no interference from the other amino acids, or themselves.
Method Parameters:
As previously stated, a is a term which is dependent on the chemical
interactions of the analytes with the system.

Therefore, it was decided

to investigate several of the chemical parameters of the method, and determine their effects on the separation of the desmosines.

The first

parameter investigated was the effect of the methanol percentage of the
mobile phase on the separation of the desmosines.

In the initial deve-

lopment of the method, the methanol percentage was varied to achieve maximum separation of the desmosines.

Qualitatively, as the methanol per-

centage increased, the retention times of the desmosines decreased, as
did their resolution.
creased.

Thus as the methanol increased, N, a, and R5 de-

It was found that above a methanol percentage of 30, the effi-

ciency (N) decreased drastically as did the separation factor, a, which
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decreased to 1.

The Rs was also found to decrease from 4.8 with 26% me-

thanol to less than 1 with a percentage above 36%.

In all cases, the

methanol percentage yielding maximal chromatographic characteristics was
determined to be between 25 and 28%.
It was also found that as the column aged, the retention times of
the desmosines decreased.

In order to offset this decrease, the concen-

tration of the methanol was lowered.

The decrease in the retention time

by the column is believed due to deterioration of the column with usage
119 Finally, it was noted that as the methanol percentage increased,
the column head pressure also increased.
The next chemical parameter investigated was the effect of the mobile phase pH on the separation of the desmosines.

From these studies,

it was determined that as the pH increased above 3.0, the k 1 values of
the amino acids decreased (Fig. 14).

It was noted that the desmosines

could effectively be separated up to a pH of approximately 3.2; however,
several of the other amino acids could not be resolved at this pH.

It

was also found that if the pH was decreased below 3.0, no substantial
effects were observed.

Therefore, it was decided to maintain the pH at

3.0.
From these studies it was determined that the pH decreased the value
of N, a, and Rs constants, similar to increasing the methanol concentration.

These interactions are believed due to the amount of ionization

of the amine groups on the amino acids with the sulfonic acid residues
of the counter ion 119 .
. Finally, the effect of the counter ion concentration was investigated.

With ion-paired systems, the solvent strength can be varied by
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k'

o.o;-------r--------,-------,...-------.
3.0

3.2

3.4

3.6

3.8

pH

Fig.

14.

Effect of ion-paired mobile phase pH on k' values of
several amino acid standards. Mobile phase consisted
of methanol/water (26/74, v/v), containing 0.01 mol/L
heptane sulfonic acid, with the pH varied from 3.0 to
3.8.
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changing the counter ion concentration 119 . Thus, by increasing the concentration of the counter ion in the mobile phase, the k' values of the
analytes can be increased, if the analyte is not fully ionized 119 .
Therefore, a change would be expected in a.

If however, the analyte is

fully ionized, little or no change should be observed in a.
When the heptane sulfonic acid concentration was increased to 0.02
mol/L, a very small increase was noticed in the k' values of the desmosines.

However, no change was observed in the a factor.

If the concen-

tration was decreased, both Des and Ide k' values were found to decrease,
substantually decreasing a.

Therefore, for this method it was decided

to maintain the heptane sulfonic acid concentration at 0.01 mol/L.
Quantitation of the Desmosines:
Once it was determined that the method would reproducibly separate
the desmosines from one another and other amino acids, their quantitation
was attempted.

In order to access their ability to be quantitated, a

standard curve was constructed, as described in Chapter 3.

Essentially,

various concentrations of Des and Ide standards were injected separately
and together, such that any deviations, with their simultaneous quantitation, would be detected.
Desmosine and Ide were found to display a linear response to the
various concentrations injected, both singly and together, when detected at 205 nm (Figs. 15, 16; circles).

Upon analysis of the curve, Des

and Ide yielded almost identical equations of the lines (y = 68.28x +
0.04 for Des, andy= 64.55x - 0.07 for Ide).

Not only did both amino

acids display similar slopes and y-intercepts, they were found to display
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15.

Standard curve (0} and recovery from hydrolyzed BSA (~)
of desmosine using the ion-paired HPLC method.
(0) Known concentrations of purified desmosine standards
injected and peak heights determined.
(~) Known concentrations of purified desmosine standards
added to BSA prior to hydrolysis. Recovery peak
heights compared to standard curve peak heights.
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Standard curve (0) and recovery from hydrolyzed BSA (~)
of isodesmosine using the ion-paired HPLC method.
(0) Known concentrations of purified isodesmosine standard
injected and peak heights determined.
(~) Known concentrations of purified isodesmosine standards
added to BSA prior to hydrolysis. Recovery peak
heights compared to standard curve peak heights.
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excellent correlation between their respective concentrations and peak
heights (r greater than 0.99 for both).
Once it was determined that the desmosines could be quantitated at
205 nm, various other wavelengths were used in their detection.
the peak height was used as the measure of quantitation.

Again,

Initailly, the

wavelength was decreased in order to increase the sensitivity of the
detection.

However, it was found that as the wavelength decreased the

baseline absorbance increased, such that the desmosines were undetectable.

This effect was due to the methanol in the mobile phase, as me-

thanol has been shown to have an absorbance cutoff at 205 nm.
When the wavelength was increased, the sensitivity for the detection
of the desmosines decreased.

While this decrease was not substantial

(approximately 10% at 215 nm), it was considered significant.

Therefore,

the desmosines were detected at 205 nm, as previously described.
From these studies it was concluded that not only would this system
separate the desmosines, but would simultaneously quantitate Des and Ide.
Once it was determined that the desmosines could be quantitated, the
reproducibility of the method was investigated.

For this precision

study,standards of Des and Ide (0.0851 and 0.0569 mmol/L, respectively)
were injected according to two schedules.

For the intra-day precision,

Des and Ide were injected 10 times daily, while for the inter-day precision, Des and Ide were injected once daily for 10 days.

In all cases,

the peak heights were determined and used in the calculations.
It was found that the standard deviations (S.D.) and the coefficients of variation (C.V.) were less than 0.2 em and 3%, respectively,
for both the intra- and inter-day precision studies (Table 16).

It was
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TABLE 16
INTRA- AND INTER-DAY PRECISION STUDIES
FOR DESMOSINE AND ISODESMOSINE DETERMINATIONS
BY ION-PAIRED HPLC
N=lO

INTRA-DAY

PEAK HEIGHT

(eM)

INTER-DAY

DES

IDE

DES

IDE

7.99

3.98

7.96

3.79

S.D.

(eM)

0.07

0.06

0.14

0.09

c.v.

(%)

0.93

1.58

1.69

2.39

DESMOSINE AND ISODESMOSINE STANDARDS
INJECTED
DAILY FOR

10

10

(0.0851

AND

0,0569

MMOL/l

TIMES PER DAY FOR INTRA-DAY PRECISION, AND ONCE
DAYS FOR THE INTER-DAY PRECISION DETERMINATIONS,
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also noted that the S.D. and the C.V. of the intra-day determinations
were approximately one-half the inter-day determinations.

This result

is to be expected, as the within day precision is almost always greater
than the between day precision 120
A C.V. of less than 5% is usually acceptable for analytical determinations 120 . Therefore, with this method displaying a low C.V. for
both the desmosines (less than 3%), it was concluded that it was well
within the acceptable limit of reproducibility for an analytical method.
Recovery Studies:
The final analytical parameter investigated was the percent recovery
of Des and Ide from various samples, to demonstrate the accuracy of the
method.
sines.

The first study utilized BSA, a protein which contains no desmoTo this protein, Des and Ide were added, prehydrolysis, and the

samples prepared as described in Chapter 3.
Following the analysis of the hydrolysates, the Des and Ide concentrations were determined, and compared to their standard curves.

Both

Des and Ide were well within the peak heights for their respective spikes
(Figs. 15, 16; triangles).

The slope andy-intercept for both the Des

and Ide spikes (y = 71.48x- 0.02 andy= 60.56x + 0.02, respectively),
correlated well with the slopes and y-intercepts of the standard curves
for Des and Ide (r = 0.99).

The range of recovery for the Des spikes

were between 98 and 102%, with an average recovery from the spiked BSA
of 99.6%.

The average recovery of Ide from spiked BSA was 98.5%, with a

recovery range from 96 to 102%.
Also, from this initial recovery study, the lower limit of detection
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for either Des or Ide was approximately 100 pmol.

Below this level, the

desmosine peak was indistinguishable from the baseline noise of the detector.
Following the determination of the recoveries from a sample which
contained no desmosines, a Des and Ide spike was added to a sample known
to contain both the amino acids.

For these studies, a canine aorta sam-

ple was obtained and prepared as described in Chapter 3.
and Ide was added prior to the hydrolysis procedure.

Again, the Des

In this study, one

sample of the aorta remained unspiked, while the remaining 5 samples were
spiked with both Des and Ide.
Upon analysis and determinations of the Des and Ide concentrations
of the unspiked and spiked samples, the recoveries were calculated, and
the observed values (ion-paired HPLC determinations) vs. the predicted
values (calculated from the amount of the spike) were plotted.
coveries for both Des and Ide were found to be excellent.

The re-

The recovery

range for Des was between 95 and 100%, with an average recovery of 97.2%.
The recovery range for Ide was determined to be between 96 and 102%, with
an average recovery of 99%.
When the observed concentrations were compared to the predicted concentrations, both Des and Ide were found to display a linear relationship
(Figs. 17, 18).

Upon statistical analysis of the recoveries, both Des

and Ide displayed similar slopes and y-intercepts (y = 0.99x + 0.002 for
Des, andy= 0.95x + 0.003 for Ide), and were found to correlate well
with their respective predicted values (r greater than 0.97 for both
amino acids).
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Recovery of purified desmosine from hydrolyzed canine
aorta as described in Chapter 3. Recovered (observed)
concentrations plotted against the predicted concentrations.
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Recovery of purified isodesmosine from hydrolyzed canine
aorta as described in Chapter 3. Recovered (observed)
concentrations plotted against the predicted concentrations.
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Canine Aorta Studies:
From all the previous analytical studies, the method was determined
to be reproducible, accurate and precise for the separation and quantitation of the desmosines 119 , 120 . This having been established, it was
decided to attempt to quantitate the desmosines, using tissue samples.
The tissue to be investigated was canine aorta (aortic arch region).
This tissue was chosen because the concentration of both the desmosines,
as well as the elastin content, is well documented 101 , 121 - 123 In this
study, the Des and Ide concentrations of the aorta samples, determined
by ion-paired HPLC, were compared to those concentrations obtained by
automated amino acid analysis (AAA).

Finally , the elastin content of

the canine aortas was estimated from the Des and Ide concentrations of
the samples, and compared to the elastin content as determined by gravimetic procedure.
Thirteen canine aortas were obtained and prepared as described in
Chapter 3.

Of the prepared, diluted hydrolysates, 10

~L

of each was in-

jected, and the desmosines quantitated as described by the ion-paired
method.

The desmosines were found to elute in a manner similar to the

Ide and Des standards, with retention times of 52 and 57 min, respectively (Fig. 19).

The other amino acids present in the hydrolysates

were also found to elute similar to their respective standards.

In all

the chromatograms of the aorta samples, one prominent peak was observed
to elute between Phe and Ide, with a k' value different from any investigated amino acid (31.50).

This peak was thought to be lysinonorleucine,

a minor cross-link found in elasti'n (see Chapter 1).
The concentrations of Des and Ide were then calculated from their
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Representative ion-paired HPLC chromatogram of
hydrolyzed canine aorta. Hydrolysate eluted with
methanol/water (26/74, v/v) mobile phase, containing 0.01 mol/L heptane sulfonic acid, pH 3.0.
Detection at 205 nm.
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respective standard curves, for each of the 13 canine tissue samples
(Table 17).

In a similar fashion, the Des and Ide concentrations of each

of the 13 samples were determined by AAA, as previously described in
Chapter 3 (Table 17).
Once the Des and Ide concentrations were determined by both methods,
the results were compared.

Both Des and Ide were found to correlate well

with the AAA, both having a linear relationship, with slopes of approximately one with small intercepts, and with correlation coefficients of
greater than 0.97 (Figs. 20, 21).

These results indicated that no sig-

nificant difference existed between the two methods of determination for
Des and Ide (p<O.OOl).
From this study it was concluded that Des and Ide concentrations
could be determined from tissue samples using the ion-paired HPLC method,
with no significant difference between the results obtained by ion-paired
HPLC, and those obtained from the accepted method of AAA 124 - 126 .
Estimation of Elastin and Collagen Content of the Aorta:
The elastin content of the aorta was estimated from the Des and Ide
concentrations 39 , 121 , 122 . For this estimation, it was initially necessary to determine the percentage of the total desmosines (Des plus Ide)
in elastin.

In order to determine this percentage, the amino acid anal-

yses of purified elastins from human and canine aorta and lung were obtained from several investigators 101 , 121 - 123 . Lung elastin was included
for several reasons: one, it has been shown that the amino acid content
of purified elastin from aorta and lung are very similar; and secondly,
the majority of recent publications on the purification and amino acid
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TABLE 17
DESMOS INE AND I SODESMOS I NE CGrlCENTRATIONS
AS DETERMINED BY HPLC AND AUTOMATED
AMINO ACID ANALYSIS

DOG

1
3
5
6

7
8
9
10
11

12
13

14
15

AUTOMATED
AMINO ACID ANALYSIS
DES (MMOLfL) IDE
0.406
0.204
0.123
0.474
0.310
0.318
0.348
0.482
0.267
0.452
0.338
0.328
0.516

0.305
0.165
0.097
0.367
0.256
0.254
0.295
0.346
0.256
0.360
0.290
0.276
O,t(S6

HPLC
DEs (MMOLIL) IDE
0.441
0.257
0.117
0.446
0.280
0.301
0.341
0.510
0.289
0.458
0.360
0.363
0.565

0.295
0.184
0.103
0.360
0.285
0.293
0.306
0.361
0.271
0.344
0.312
0.297
0.473

DESMOSINE AND !SODESMOSINE CONCENTRATIONS OF 13 CANINE AORTA SAMPLES
PREPARED AS DESCRIBED IN CHAPTER 3.
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Regression analysis of desmosine concentrations from 13
hydrolyzed canine aortas as determined by AAA and ionpaired HPLC.
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Regression analysis of isodesmosine concentrations of 13
hydrolyzed canine aortas as determined by AAA and ionpaired HPLC.
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content of elastin has utilized lung tissue 101 , 121 - 12 3.
Upon examination of the amino acid content of these elastin preparations, it was found that there are approximately 2-4 total desmosine
residues per 1000 residues.

Thus in order to determine the percent total

desmosines in elastin, the molecular weight

(~~)

contribution of the

total desmosines was divided by the total MW of the 1000 residues of
elastin and then multiplyed by 100.
From these determinations, it was found that approximately 1.3% of
elastin is total desmosines, or for every mg elastin, 13
buted by the desmosines.

~g

is contri-

To further substantiate the use of the purified

lung elastin in the percentage determination, when the percent desmosines
were calculated in the lung preparation only (not incorporating any data
from the aorta), the percent was again found to be 1.3.

.

Thus for the elastin calculations, the Des and Ide concentrations
were first converted from mmol/L to nmol total desmosines/mg aorta FFDW.
The nmol total desmosines were converted to
MW of the desmosines, yielding a

~g

~g

total desmosines by the

total desmosines/mg aorta FFDW.

The

elastin content was finally arrived at by using the conversion factor of
13

~g

total desmosines per mg elastin.
These calculations were performed on the Des and Ide results, ob-

tained by ion-paired HPLC and AAA, from the 13 canine aorta samples
(Table 18).

Upon statistical analysis, both methods were found to be in

good agreement with one another, displaying a linear relationship (Fig.
22), with a slope of approximately one (y = 0.91x +53), and an r value
of 0.9326, indicating excellent correlation between the two methods
(p<0.001).

Also, no significant difference was found between the mean

TABLE 18
ELASTIN AND COLLAGEN CONTENT OF CANINE AORTA
% ELASTIN

DOG

AAA

1
2
5
6
7
8
9
10

38.9
30.9
25.5
IJ3,8
38.5
41.0
44.8
41.2
31.3
45.2
LJ2, 5
37.8
46.2

11

12
13
14
15
~-------------

% COLLAGEN

HPLC

UNCORR~

40.3
37.1
25.5
42.0
38.5
42.5
45.0
43.5
34.9
44.6
LJ5 .LI
1Jl.2
50.9

28.6
46.9
52.0
30.5
27.4
24.9
21.2
27.2
30.4
28.8
26.9
23.6
29.0

%CTP**

CORR.*
22.5
41.3
48.1
24.1
20.7
18.4
14.3
25.0
25.0
22.0
20.0
17.3
21.3

UNCORR.*
68.0
84.0
77.5
72.5
65.9
67.4
66.2
70.7
65.3
73.4
72.3
64.8
79.9

CORR.*
62.8
78.4
73.6
66.1
59.2
60.9
59.3
64.0
59.9
64.6
65.4
58,5
72.2

·--·

------------

ELASTIN AND COLLAGEN CONTENT (UNCORRECTED AND CORRECTED) CALCULATED AS DESCRIBED IN CHAPTER

* UNCORR ~
** %CTP;

UNCORRECTEDj

CORR. ;

4,

CORRECTED

%CONNECTIVE TISSUE PROTEIN, AS DETERMINED BY PERCENT ELASTIN PLUS COLLAGEN.

ELASTIN coNTENT DETERMINED FROM

DEs AND IDE auANTITATION BY JON-PAIRED HPLC
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0
..J:::.

105

....

~
0
Ll.

Ll.
.....
w 40Q

N=13
SLOPE=0.91
Y-INTERCEPT=53.0 mg elastin;g tissue
r=0.9326
X-MEAN =390.5 ±63.0 mg elastin;g tissue
Y-MEAN-=408.8 ±61.6 mg elastin/Q tissue

:;)
(/)
(/)

i=
(.)

i=
(.) a: 30Q

..Jo
a.<

:1:~

~

1-

(/)

:5w

20Q

0

E

10Q

Q

10Q

200.
300.
400.
mg ELASTIN/ g AORTIC TISSUE (fFDWl

500.

AMINO ACID ANALYZER

Fig.

22.

Regression analysis of elastin content of 13 canine
aortas, calculated from Des and Ide concentrations as
determined by AAA and ion-paired HPLC.
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elastin content obtained from AAA (390.5 ± 63 mg elastin/g aorta FFDW)
and the mean elastin content as determined by ion-paired HPLC (408.8

±

62 mg elastin/g aorta FFDW).
Once the elastin content had been calculated from the Des and Ide
concentrations, it was decided to compare these results to the elastin
content of the same canine aorta samples as determined by a gravimetric
procedure.

This method of elastin determination relied on the insolubi-

lity of the protein through several extractions including; a 1% sodium
chloride extraction, followed by several autoclavings at 121 °C and 18
psig, until the resulting supernatant was devoid of protein, and finally,
the remaining residue was extracted with hot (100 °C) 0.1 mol/L sodium
hydroxide to remove any remaining non-elastin proteins.

The residue remaining following the alkali extraction was considered elastin 27 , 29 .
This procedure was performed on 5 canine aorta samples, and the
elastin content as determined by both methods (gravimetric and calculated) were compared.

The average elastin content obtained by the cal-

culation method (408.7

±

61 mg elastin/g aorta FFDW) was found to be

somewhat higher than the elastin content as determined by the gravimetric
procedure (325.1 ± 27.5 mg elastin/g aorta FFDW), though no significant
difference between the two methods was noted.
From this study it was determined that no significant difference
existed between the gravimatric and calculation procedures for the estimation of the elastin content of the canine aorta.

This finding, how-

ever, may be biased by one result which yielded the same elastin content
by both procedures.

If this result was not included, a significant in-

crease was observed in the elastin content when

dete~ined

by HPLC.
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Aorta Collagen Determinations:
Though elastin has been shown to be a major component of the aorta,
another major connective tissue protein, collagen, is also present.
Therefore, in order to determine the total connective tissue protein content of the aorta, the collagen content of the aorta samples was determined.

Collagen content is frequently estimated by the hydroxyproline

(Hyp) content of the tissue, in a manner similar to the use of Des and
Ide for the estimation of the elastin content 40 . Therefore, in order to
determine the collagen content, the percent Hyp in collagen was determined.

This determination was based on the amino acid analyses of various purified collagen preparations 127 - 129 It was found that there were
between 88 and 95 Hyp residues per 1000 residues of collagen.

From this,

the percent Hyp in collagen was calclated, by the previously described
methods, to be 11.1%.

Therefore, for every mg collagen, 111

~g

is con-

tributed by Hyp.
Using this Hyp percentage, the collagen content of the 13 canine
aorta samples were determined as described in Chapter ·3 (Table 18).

It

was found that the collagen content of the aortic samples varied from 20
to 50%, with an average collagen content of 305.7
g aorta FFDW.

±

110.6 mg collagen per

The total connective tissue protein content of the aorta

samples were found to vary from 60 to 80% of the total weight, with an
average of 700.0 mg total connective tissue protein/g aorta FFDW.

During

the course of this study it was noted that generally, as the elastin content increased, the collagen content decreased.
As previously mentioned, the collagen content is derived from the
quantitation of Hyp.

However, other proteins, specifically elastin, have
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been shown to contain Hyp 101 , 121 - 123 . Since it has been shown that the
aorta contains a significant amount of elastin (approximately 40%), the
Hyp from elastin is being included in the total amount of Hyp in the tissue.

Thus, non-collagen Hyp would tend to elevate the collagen levels

in tissues which are rich in elastin.
In order to determine if this apparent increase in the collagen content would be significant, the Hyp component of elastin was calculated
by determining the percent Hyp in purified preparations of elastin. It
was found that elastin contained approximately 1.7% by weight Hyp 101 ,
121-123

This non-collagen Hyp was then subtracted from the total Hyp

and the collagen content was recalculated, to obtain a "corrected" collagen content of the canine aortas (Table 18).

Upon analysis of the

"uncorrected" and "corrected" collagen content, it was found that the
difference between the uncorrected and corrected values was significant
(p<0.01), and that the corrected values were approximately 10% less than
the uncorrected values.

It was also noted that the largest apparent de-

crease in the collagen content occurred in samples which contained high
percentages of elastin.
As previously stated, it was found that as the elastin content of
the aorta increased, the collagen content was found to decrease.

When

the various elastin and collagen percentages of the 13 canine aortas were
plotted, an inverse relationship was, in fact, found to exist (Fig. 23).
This relationship may be biased by the inclusion of two samples which
were found to be high in collagen and low in elastin (Dogs 2 and 5). If
these two samples were excluded from the population no relationship could
be inferred.

However, no justification existed for their exclusion,
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Relationship between elastin and collagen (corrected)
content for canine and human aortic tissues. Elastin
calculated from Des and Ide concentrations as determined
by ion-paired HPLC. Collagen content calculated from
corrected Hyp concentrations.
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therefore, they were included in the population.
Effect of Age on the Elastin and Collagen Content of Human Aortas:
Having determined the validity of both the ion-paired HPLC method
for the quantitation of the desmosines, and their subsequent use for the
estimation of the elastin content, an investigation of the effect of age
on both the elastin and collagen content of human aortic arch tissues was
undertaken.

For this study, samples of human aorta (aortic arch region)

were obtained from eleven post-mortem examinations at Loyola University
Medical Center.

Only tissue that on gross examination by a pathologist

appeared free of pathological processes were used in this study.

The age

and sex of each subject from whom the tissues were obtained were noted
(Table 19).

The all Caucasian population included 5 females and 6 males,

ranging in ages from 2 to 90 years.
Following the tissue preparation (as described in Chapter 3), the
Des and Ide concentrations were determined by both the ion-paired HPLC
method, and by AAA (Table 20).

It was noted that the ion-paired HPLC

chromatograms obtained from the human aorta hydrolysates were very similar to the chromatograms obtained from the canine hydrolysates, with Ide
and Des eluting at 59 and 66 min, respectively (Fig. 24).
Following the quantitation of the desmosines in the human aorta
hydrolysates, the percent elastin in each was estimated as previously
described in the canine aorta studies (Table 21).

From these calcula-

tions, it was found that the results obtained from the ion-paired HPLC
method again correlated well (r

= 0.96)

with the results obtained via the

AAA, yielding a linear relationship between the two methods (y = 1.00x +
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TABLE 19
DEMOGRAPHICS OF HUMAN SAMPLES

SAMPLE

LAB # *

SEX

AGE

1

81A-21 ,

M

2

2

81A-20

F

5

3

81A-22

M

17

4

81A-30

F

34

5

81A-31

M

58

6

81A-19

F

66

7

81A-33

M

66

8

81A-32

F

67

9

81A-18

M

70

10

81A-34

M

70

11

81A-17

F

90

(YRS)

AGE AND SEX INFORMATION OF SAMPLES OBTAINED FROM HUMAN SUBJECTS,

*

lABORATORY ASSIGNED NUMBER,
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TABLE 20
DESMOSINE AND ISODESMOSINE CONCENTRATIONS OF HUMAN AORTIC ARCH
TISSUES AS DETERMINED BY HPLC A~D AUTOMATED
AMINO ACID ANALYSIS

SAMPLE
1
2
3
4

5
6
7
8

9

10
11

AUTOMATED
AMINO ACID ANALYSIS
DES (MMOLfL) IDE
0.174
0.114
0.177
0.123
0.106
0.131
0.114
0.102
0.131
0.117
0.098

0.155
0.119
0.130
0.103
0.071
0.088
0.094
0.062
0.076
0.095
0.078

HPLC
DEs (MMOLIL) IDE
0.186
0.139
0.176
0.118
0.110
0.132
0.116
0.109
0.147
0.116
0.094

0.149
0.113
0.126
0.088
11,083
0.098
0,086
0.083
0.101
0.094
0.072

DESMOSINE AND ISODESMOSINE CONCENTRATIONS OF HUMAN AORTIC ADCH
SAMPLES PREPARED AS DESCRIBE IN CHAPTER 3, ALL SAMPLES RUN IN
DUPLICATE,
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Representative ion-paired HPLC chromatogram of hydrolyzed human aorta. Hydrolysate eluted with methanol/
water (26/74, v/v) mobile phase containing 0.01 mol/L
heptane sulfonic acid, pH 3.0. Detection at 205 nm.

TABLE

21

ELASTIN AND COLLAGEN CONTENT OF HUMAN AORTIC ARCH TISSUE

1
2
3
4
5
6
7
8
9
10
11

%CTP**

%COLLAGEN

% ELASTIN

SAMPLE

AAA

HPLC

UNCORR.*

CORR.*

45.8
31.2
42.7
31.5
27.0
24.6
30.5
28.4
33.0
29.5
24.5

46.6
35.1
42.1
28.6
26.8
26.9
32,0
27.8
35.8
30.4
23.1

40.6
44.7
40.4
31.2
36,0
37.0
. 26.7
33.1
30,5
32.7
37,9

33.5
39.5
33.9
25.1
31.9
32.9
22.7
28.9
25.0
28.0
34.4

UNCORR.*

87.2
79.8
82,5
59,8
62,8
63,9
58,7
60.9
66,3
63.1
61.0

CORR.*

80.1
74.6
76.0
53.7
58.7
59,8
54.7
56.7
60,8
58.4
57,5

ELASTIN AND COLLAGEN (UNCORRECTED AND CORRECTED) CONTENT CALCULATED AS DESCRIBED IN CHAPTER
• UNCORR.
** %CTP

= UNCORRECTEDi CoRR,
= %CONNECTIVE TISSUE

4,

: CORRECTED
PROTEIN~

AS DETERMINED BY PERCENT ELASTIN PLUS COLLAGEN,

ELASTIN CONTENT DETERMINED FROM DES AND IDE QUANTITATION BY ION-PAIRED HPLC,
.......
.......
.J::>
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0.6).

Therefore, the elastin content, as determined by the ion-paired

HPLC quantitation of the desmosines was utilized in all further analyses
of the human aorta samples.
Upon statistical analysis of the human aorta samples, it was found
that they segregated into two groups.
mean elastin content of 412.6

±

The first group (age 2-17) had a

58.1 mg/g aorta FFDW, while the second

group (age 34-90) was found to have a mean elastin content of 288.7 ±
38.1 mg/g aorta FFDW.

These two means were determined to be statisti-

cally different (p<0.01).

From these results it was concluded that with

age, the elastin content of the aorta (aortic arch region) decreased
significantly.
Following the determination of the elastin content of the human
aorta samples, the collagen content of these same samples were determined, as previously described in the canine aorta study.

Again, both

the uncorrected and corrected collagen content of each sample was calculated (Table 21).
Upon statistical analysis, it was found that the uncorrected collagen content of the aorta samples were segregated into 2 age groups, identical to the age groups found in the elastin study.

The first group (age

2-17) had a mean collagen content of 419.0 ± 24.5 mg collagen/g aorta
FFDW, while the second age group {34-90) was found to have a mean collagen content of 331.2 ± 37.0 mg collagen/g aorta FFDW.
were found to be statistically different (p=0.05).

These two means

However, when the

correction for the non-collagen Hyp content of the aorta samples were
made, and the corrected collagen content.determined, it was found that
while the younger age group had a somewhat higher mean collagen content
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than the older group (356.0 ± 34.4 mg collagen/g aorta FFDW vs. 286.9 ±
45.5 mg collagen/g aorta FFDW), and that there was a decrease in the collagen content from young to old, the significance observed in the uncorrected collagen diminished.

This decreasing tendency in the collagen

content of aortic samples with age has been observed by other investigators 134,135
From these results it was concluded that the significant age difference observed in the uncorrected collagen content between of two
groups may be due to the Hyp content of the elastin.

Thus, when the

non-collagen Hyp is subtracted from the total Hyp content of the tissues,
the age difference previously observed in the uncorrected collagen content diminished, although a decreasing trend in the corrected collagen
content with age is still observed.

These results stress the necessity

to correct for the non-collagen Hyp content in tissues which are rich in
elastin, such as the aorta.
Following the collagen determinations, the percent connective tissue protein in the human aortas was calculated as previously described
(Table 21).

Again, a significant difference was observed between the two

age groups, whether the uncorrected or corrected collagen content was
used in the calculations.

Using the corrected collagen content of the

aortas, the mean percent connective tissue protein for the 2-17 year
group was determined to be 76.9 ± 2.85%, while the mean percentage determined in the 34-90 year group was 57.5 ± 2.4%.

Clearly, these results

show a significant decrease (approximately 1/3) in the total connective
tissue component of the aorta with age (p<O.OOl). This result is to be
expected since this research has shown the elastin, and possibly, the
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collagen content of the aorta decrease with age.
Hydroxyproline Determination by Ion-Paired HPLC:
During the development of the ion-paired HPLC method for the quantitation of the desmosines, it was observed that standards of Hyp and Pro
displayed k' values different from the other amino acids investigated
(Table 14).

From this finding, it was thought that it may be possible to

simultaneously quantitate the Hyp and the desmosines in tissue hydrolysates, thereby yielding an estimate of both the elastin and collagen content from one analysis.
I

However, it was found that that the mobile phase

which maximized the separation of the desmosines failed to sufficiently
resolve Hyp and Pro in the tissue hydrolysates.
In an attempt to separate Hyp from Pro and the other amino acids in
the hydrolysate, the methanol percentage of the mobile phase was decreased to 19%.

At this methanol percentage, Hyp was observed to completly

separate from Pro (Fig. 25).

The elution profile of the desmosines at

this decreased methanol percentage, however, was such that they were unable to be quantitated, the peaks being very broad and unsymmetrical, due
to the extended length of time on the column.
It may still be possible to quantitate Hyp with the desmosines if a
gradient elution technique is applied to the existing ion-paired HPLC
method.

With this system, the methanol percentage of the mobile phase

would be gradually increased from 19% to 26% during the course of the
analysis.

Therefore, the Hyp, eluted at the lower methanol percentage,

would separate from the other amino acids, and the desmosines, eluted at
the higher methanol percentage, could still be quantitated.
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25.

Chromatogram of Hyp and Pro separation by ionpaired HPLC. Amino acid standards eluted with
methanol/water (19/81, v/v), pH 3.0, containing
0.01 mol/L heptane sulfonic acid. Amino acids
detected at 205 nm.

CHAPTER 5
DISCUSSION
Elastin is one of the major connective tissue proteins of the body,
and is unique in that it displays both elasticity and tensile strength.
This protein has been implicated in several pathological conditions, including atherosclerosis, emphysema, and a rare hereditary disease, pseudoxanthoma elasticum.

Thus, it would be advantageous to determine the

amount and composition of elastin in both 11 normal 11 and
processes.

11

pathological 11

However, this information is lacking in that the major source

of data pertaining to the quantitation of elastin is derived from gravimetric determinations of the residue remaining following several extraction procedures.
These extraction results have been shown to be non-reproducible when
compared to both with-in and between method evaluations 14 , 24 - 26 . This
variability of results has been partially explained by the glycoprotein
content of the remaining residue, which is often defined as elastin.
This glycoprotein content has been shown to vary considerably with the
source and age of the tissue, and may be due to the method utilized to
extract the various other proteins 46 , 86 . Also, these extraction methods
are tedious, require several days for completion, and prone to methodological errors.
Recently, a method for the estimation of elastin, which relies on
the cross-linking amino acids Des and Ide, has been proposed 39 This
method utilizes the quantitation of the two derived amino acids as an
119
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index to the amount of elastin present in the tissue, just as the quantitation of Hyp is frequently used as an index to the amount of collagen
present 49 • This inference is possible because Des and Ide have only
been found in elastin and the non-elastin protein in egg shell membranes.
This method of quantitation has several advantages over the extraction procedures.

For one, after the tissue is dried and defatted, it is

simply hydrolyzed in one step, which negates any errors associated with
the possible loss of elastin by extraction procedures.

Secondly, by its

nature, the procedure is less tedious, and eliminates several methodological errors introduced by the extraction procedures.
With this method, the desmosines are routinely quantitated by automated amino acid analysis.

While this method of quantitation has been

the accepted technique, there are disadvantages associated with the amino
acid analyzers.

For one, relatively few laboratories have a completely

automated amino acid analyzer at their disposal, the instrument being.
somewhat cost prohibitive.

Secondly, amino acid analysis is a time con-

suming procedure, the average analysis requiring 3 to 6 hours.

Finally,

the limit of detectability for the desmosines with an amino acid analyzer, utilizing ninhydrin from detection, is at best 5 nmols, thereby
limiting its use to tissues rich in elastin (aorta, lung) unless concentration procedures are utilized.
The results described in Chapter 4 show that an alternative method
of quantitation of the desmosines is possible.

This ion-paired HPLC

method for the separation and quantitation of Des and Ide was shown not
only to correlate well with the accepted method of quantitation, but to
rival the amino acid analyzer in terms of general availability (not as
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cost prohibitive), analysis time (less than 1 hour for complete analysis
with no column regeneration), and sensitivity (lower limit of detection
being approximately 100 pmol).
This research has also shown that the estimation of the elastin content of canine aortic tissues, when calculated from the concentration of
the desmosines, as opposed to determination by gravimetric procedures,
were higher in 4 of the 5 samples studied.

Yet due to one high gravimet-

ric result, the difference observed between the two methods was not significant.

This finding may be biased by the limited number of samples

.investigated.

The higher elastin content obtained by the HPLC method

in the 4 samples mey be explained by sample degradation due to the harshness of the extraction procedures utilized in the gravimetric method 14 •
24-26

The elastin results obtained by the quantitation of the desmo-

sines, when compared to those previously reported, were nund to be nearly identical 101 .
When the elastin content of the canine aortas were combined with
their respective collagen contents, it was observed that there was an inverse relationship between the two connective tisue proteins, and that
the elastin plus collagen content of the canine aortas accounted for approximately 2/3 of their total FFDW.

If, however, the non-collagen Hyp

content of the aortas (elastin contains approximately 1.7% Hyp) was subtracted from the total Hyp content, and the collagen determined using
these corrected concentrations, a significant decrease of approximately
10% was observed in the canine aortas.

This is the first report of the

overestimation of the collagen content in tissues rich in elastin.
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hydrolysates (aortic arch region), it was observed that the elastin content varied according to the age of the individual.

It was found that

in the 11 human aorta samples studied, the highest elastin content occurred in the first two decades of life, and decreased thereafter.

These

findings have been substantiated by others, though the absolute decrease
varied between investigators, depending on the method utilized for the
estimation of the elastin content 130 - 132 .
The average elastin content of the human aortas was found to be
somewhat less than those previously published 101 • This difference may be
accounted for by the age dependence associated with the elastin content,
and the sample population being skewed towards the aged.
The collagen content of the human aortas were again shown to be inversly proportional to the elastin content, and this relationship was observed to fall into the 2 age groups described for the elastin content
(p=0.05).

Also, a substantial decrease was noted in the collagen con-

tent of the human aortas when the non-collagen Hyp from elastin was subtracted from the total Hyp content.
There have been conflicting reports on the age dependence of the
collagen content of human aortas, varying from a decrease with age to reports of increases observed in the collagen content with age 133 - 135 .
These conflicting results may, in part, be explained by the non-collagen
Hyp contribution of elastin.

However, no definitive statement can be

made in regard to the significance of the dependence of the collagen content with age from the results qescribed in Chapter 4.

These findings,

however, further emphasize the necessity for correcting for the Hyp content of elastin, in tissues rich in this protein.
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Finally, the connective tissue protein content of the human aortas
was determined to be approximately 2/3 the total FFDW, using the corrected collagen content.

This value is approximately 10% higher than
those of a previous report 18 . However, the method of elastin and collagen content utilized in that report involved extremely harsh extraction
procedures, which could lead to sample degradation.
As previously described in Chapter 4, an unknown peak appeared on
the chromatograms of all the canine and human aorta hydrolysates.

This

peak was speculated to be lysinonorleucine, a minor cross-link found in
elastin.

With further observations, the relative peak height was found

to increase with the age of the human aorta samples.

If this peak is in

fact lysinonorleucine, perhaps an inverse relationship may exist between
it and the the desmosines.

Thus with age, as the concentration of the

desmosines decrease, the concentration of lysinonorleucine would increase.

This finding has been substantiated by other investigators 130 .

This finding leads to a problem associated with the measurement of
elastin by the quantitation of the desmosines, or any other amino acid.
This problem is the question of possible changes in the absolute number
of cross-links (Des, Ide, or lysinonorleucine) per unit elastin with
time.

There is some evidence that the Des and Ide cross-links in early
fetal elastin is very low, and then increases in late fetal elastin 136

Also, there is some evidence of a decrease in the number of Des and Ide
cross-links per unit elastin in aged individuals 130 . If, in fact, this
occurs, an argument can be made for a concomitant increase in the lysinenorleucine cross-links, with a decrease in the number of Des and Ide
cross-links.

Assuming that the Des and Ide cross-links are required for
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the elasticity and tensile strength displayed by the elastin molecule, a
decrease in their absolute number, with a concomitant increase in the
non-functional lysinonorleucine cross-links, may explain the "brittleness" often associated with aging of the aorta.
Yet, with these drawbacks, it may well be that the quantitation of
the desmosines for their use as an index to the elastin content is as
good as index as the others thus far suggested for postnatal measurements.

This would especially be true in dealing with tissues from a

given species, of similar age.
Recently, 3 other methods have been developed for the quantitation
of the desmosines for use in the estimation of elastin 137 - 139 The
first of these methods relies on the Hyp content of the tissue to determine both the elastin and collagen content 137 While, this method would
offer simultaneous quantitation of the two connective tissue proteins,
there are certain drawbacks associated with it.

For one, since Hyp is

contained in both elastin and collagen, each would be susceptible to contamination from one another, thus tending to increase their amounts.
Secondly, these methods rely on extraction procedures, whose problems
have been previously described.

Both of these problems can be eliminated

if Des and Ide are utilized in place of the Hyp, since Des and Ide are
specific markers for elastin, and their quantitation requires no extraction procedures.
Another method recently developed employs an RIA for the quantitation of desmosine 138 . Undoubtedly, this method would be more sensitive
than any method previously described.

However, this method is very de-

pendent on antibody production to desmosine, which has been shown to be
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a difficult procedure, by both the developers of the RIA method and in
this research (Chapter 4).

Also, the time of the assay is somewhat

limiting, in that it requires a long equilibration procedure.
Finally, Faris and co-workers have reported using a HPLC system similar to the ion-exchange method investigated during the course of this
study, for the quantitation of the desmosines 139 Though their system
fails to resolve Des from Ide, they claim to quantitate the total desmosine concentration by detection at 275 nm.

While this method may be

useful as a preparative procedure, the absolute quantitation of the desmosines would be suspect for several reasons.

For one, their method as-

sumes that the molar absorbance coefficients of Des and Ide are identical at 275 nm, however, their data fails to confirm this.

Secondly,

their method of quantitation assumes the Des to Ide ratio to be constant.
This, however, was not shown in their report, in fact, the Des to Ide
ratio has been shown to vary from tissue to tissue 101 , 121 - 123
It was
for these reasons that the ion-exchange method was abandoned during the
early HPLC investigations in this research.
Therefore, the ion-paired HPLC method for the quantitation of the
desmosines, and their subsequent use for the estimation of the elastin
content, is clearly as good as, if not superior, to the methods previously described.

Also, with further refinements (gradient elution), simul-

taneous quantitation of Hyp, Des, and Ide may be possible with the ionpaired HPLC method.

Thus the quantitation of these 3 amino acids from

one analysis would yield an estimation of both the elastin and collaqen
content, negating the use of a separate assay for Hyp.
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APPENDIX A
PREPARATION OF EHRLICH S REAGENT:
1

Solution A:
To 25 ml of cold absolute ethanol, 3.42 ml of concentrated sulfuric
acid was slowly added.

The mixture was kept cooled until needed.

Solution B:
To 25 ml of cold absolute ethanol, 15 g of para-dimethylaminobenzaldehyde was added and dissolved.
Reagent:
Solution A was slowly added to solution B (1:1) in an ice bath.
The reagent was stable for 4 weeks if stored in a cold dark room.

APPROVAL SHEET
The dissertation submitted by H. Patrick Covault has been read and '
approved by the following committee:
Albert A. Dietz, Ph.D., Director
Professor Emeritus, Biochemistry and Biophysics
Loyola University of Chicago
Edward W. Bermes, Jr., Ph.D.
Professor, Biochemistry and Biophysics and Pathology
Loyola University of Chicago
Mary Druse Manteuffel, Ph.D.
Associate Professor, Biochemistry and Biophysics
Loyola University of Chicago
Allen Frankfater, Ph.D.
Associate Professor, Biochemistry and Biophysics
Loyola University of Chicago
Herndon G. Shepherd, Jr., Ph.D.
Adjunct Associate Professor, Biochemistry and Biophysics
Loyola University of Chicago
M. Paul Serve•, Ph.D.
Professor, Chemistry
Wright State University
Herbert M. Rubinstein, M.D.
Associate Professor, Medicine
Stritch School of Medicine, Loyola University of Chicago
The final copies have been examined by the director of the dissertation
and the signature which appears below verifies the fact that any necessary changes have been incorporated and that the dissertation is now
given final approval by the Committee with reference to content and form.
The dissertation is therefore accepted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy.

Director

